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ABSTRACT 
Background: Common mental disorders (CMDs; anxiety disorders, depression, insomnia 
and stress-related disorders) cause significant suffering, reduced functioning and impaired 
quality of life. Cognitive behavior therapy (CBT) is an effective treatment, but there is 
considerable room for improvements in outcomes. Increased knowledge regarding potential 
mechanisms of change in CBT could inform treatment development. Investigation of both 
psychological and inflammatory processes could be one way of moving the field forward.  
Aims: The aim of this thesis was to investigate processes and correlates of therapeutic change 
in CBT for CMDs. Based on two clinical trials set in primary care in which CBT for CMDs 
were tested (Study I and II), this thesis investigated mediators of change in CBT for 
exhaustion disorder (Study III), processes of change in CBT for social anxiety disorder 
(Study IV), and inflammatory correlates of change in CBT for CMDs (Study V). 
Methods: In the clinical trials (Study I, N = 211; and Study II, N = 396), primary care 
patients with CMDs were treated with CBT, delivered in different formats. Based on the 
effects found in these trials, further analyzes were conducted in Study III, IV and V, with 
regard to processes related to outcome. In Study III, mediators of change were analyzed in 
patients with a primary exhaustion disorder (N = 82), randomized to CBT or another active 
psychological treatment. In Study IV, the effect of changes in proposed maintaining 
processes were analyzed in relation to symptom change in guided self-help CBT for social 
anxiety disorder (N = 61). In Study V, inflammatory cytokines were measured before and 
after treatment with CBT and analyzed in relation to psychiatric symptoms (N = 367).  
Results: The results of the clinical trials (Study I and II) showed beneficial effects of 
disorder-specific CBT for CMDs. In Study III, CBT led to larger effects on symptoms of 
exhaustion than the comparator, and this difference in effects was mediated by improvements 
in sleep quality and perceived competence. In Study IV, several of the putative change 
processes (i.e., estimated probability and cost of negative social events, self-focused attention, 
avoidance, and safety behaviors) predicted subsequent changes in social anxiety. However, 
all of these processes except for avoidance were also predicted by prior symptom reduction. 
In Study V, we found no robust associations across the study sample between inflammatory 
cytokines and psychiatric symptom severity. Further, the marked symptom improvement was 
not tracked by reductions in cytokines.   
Conclusions: CBT for patients with CMDs in primary care yielded favorable effects on 
psychiatric symptoms. In CBT for exhaustion disorder, sleep disturbance and perceived 
competence may be important treatment targets. In social anxiety disorder, several of the 
proposed maintaining processes seem to be part of positive reciprocal cycles, where 
improvements in processes and symptoms influence each other. Avoidance showed a 
unidirectional effect on subsequent symptoms and might thus be of specific clinical 
relevance. The results also suggest a limited role of inflammatory processes in symptomatic 
improvements following CBT for CMDs.  
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1 INTRODUCTION 
 
Hungarian physician Ignaz Semmelweis proposed, in mid 19th century,  that hand wash could 
be a vital step towards decreasing childbed mortality 1. He suggested that cadaverous matter, 
carried by medical students from autopsy room to mother in labor within the hospital, was the 
pathological pathway that caused maternal death. Later, germ theory of disease with the 
discovery of microorganisms made progress with wide-reaching consequences.  
Analogously, increased knowledge on how changes unfold in psychological treatment has the 
potential to greatly improve outcomes. There are today evidence-based treatments for several 
of the most common psychiatric disorders. Nonetheless, many patients are not helped 
sufficiently. To move the field forward, and ultimately be of better help, we need to know 
more about how change comes about in treatment. From the perspective of a therapist, this 
concerns what should be said and done to promote change in patients, or their context, that is 
instrumental for therapeutic effects. Maximizing therapeutic improvement is not only the 
main goal for patients, it is presumably the greatest reward working as a psychologist.  
 
    Stockholm, January 2019 
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2 BACKGROUND 
2.1 COMMON MENTAL DISORDERS AND MAINTAINING PROCESSES 
2.1.1 Definition of common mental disorders 
Anxiety disorders, depression, sleep disturbance and stress-related disorders are highly 
prevalent 2-6 and associated with significant suffering, reduced functioning, and impaired 
quality of life 7-9. These disorders are sometimes referred to as common mental disorders 
(CMDs)I. Specifically, in this thesis CMDs denote the disorders displayed in Table 1. These 
disorders, with the exception of exhaustion disorder, are defined according to the Diagnostic 
and Statistical Manual of Mental Disorders (DSM), the most widely used taxonomy for 
psychiatric syndromes. The core symptoms for each CMD according to DSM-5, the fifth and 
current version of the system 11, are displayed in Table 1. Core features of exhaustion 
disorder, a disorder accepted in the Swedish version of the International Statistical 
Classification of Disease and Related Health Problems, tenth revision (ICD-10) 12, are also 
shown in Table 1. 
Although CMDs are covered broadly in the present thesis, particular focus is placed on the 
investigation of processes in exhaustion disorder (ED) and social anxiety disorder (SAD). 
Therefore, these disorders will be described in more detail. ED is classified among reactions 
to severe stress, ICD-code F43.8 in the Swedish version of the ICD-10 12. The main 
characteristic is prolonged exposure to non-traumatic stressors, which has resulted in aversive 
cognitive, emotional and physical symptoms. Symptoms of psychological and physical 
exhaustion have to be present for at least 2 weeks, developed as a consequence of identifiable 
stressors present for at least 6 months. A significant lack of psychological energy dominates 
the picture, combined with disturbed concentration or memory, decreased ability to cope with 
demands, emotional instability, sleep disturbance, substantial physical weakness and physical 
symptoms such as ache, palpitation, dizziness, or sensitivity to sound. Symptoms should 
cause clinically significant suffering or impairment 12,13. ED frequently co-occurs with 
depression, anxiety and sleep disturbances, but can occur without these conditions 13,14. 
Notably, clarifying its relation to other disorders, especially depression, was an important 
aspect of development and classification of ED 12. The concept of burnout, and particularly 
clinical burnout, can be viewed as an international equivalent to ED 14. A main difference, 
however, is the focus on work stressors in burnout, while ED criteria do not explicitly point 
to the source of stress. Rather, stressors in ED often reside both in work and non-work life 15. 
In Sweden, ED is one of the leading causes of long-term sick leave 16. 
SAD is defined according to DSM-5 11 by: (a) Marked fear of one or more situations where 
the individual is exposed to scrutiny by others; (b) The individual fears acting in a way, or 
showing anxiety, that will lead to being negatively evaluated; (c) The social situations almost 
                                                 
I The term often refers to anxiety disorders and depression only 10, but will include sleep disturbance and stress-
related disorders in the present thesis because of their high prevalence. 
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always provoke anxiety; (d) The social situations are avoided or endured with intense fear or 
anxiety; (e) The fear/anxiety is out of proportion to actual threat; (f) The 
fear/anxiety/avoidance has lasted 6 months; and (g) The fear/anxiety/avoidance leads to 
significant distress or functional impairment. The studies in the present thesis were conducted 
before the change from DSM-IV to DSM-5. Although some changes in diagnostic criteria 
have been made that may have clinical implications (e.g., the shift from focusing on 
embarrassment and humiliation to the broader fear of negative evaluation may capture a 
larger group of patients) 17,18, the criteria are largely similar in the two versions. 
Table 1. Core symptoms for each common mental disorder 
Disorder Core symptoms (duration criteria) 
Social anxiety disorder      A persistent fear of one or more social situations where the individual is 
exposed to scrutiny by others, associated with fear of being negatively 
evaluated (> 6 months)     
 
Panic disorder  Recurring, unexpected panic attacks, associated with worries about additional 
attacks and/or their implications and/or behavioral changes (> 1 month)           
                                            
Generalized anxiety disorder Excessive worry concerning a number of events, and difficulties to control the 
worry (> 6 months) 
 
Obsessive-compulsive disordera Presence of obsessions (recurrent and persistent thoughts, urges, or impulses; 
associated with anxiety or suffering) and/or compulsions (repetitive behaviors 
or mental acts, aimed at reducing anxiety or preventing feared outcomes) 
 
Post-traumatic stress disordera Exposure to a traumatic event, leading to intrusive symptoms; avoidance of 
trauma-related stimuli; alterations in cognitions and mood; and alterations in 
arousal and reactivity (>1 month) 
 
Specific phobia Intense fear or anxiety when exposed to specific objects or situations (> 6 
months) 
 
Major depressive disorder Consistent depressed mood and/or loss of interest/pleasure in daily activities 
(>2 weeks) 
 
Insomnia Difficulties initiating or maintaining sleep, or non-restorative sleep (>3 
months, at least 3 nights per week) 
 
Adjustment disorder Emotional or behavioral symptoms in reaction to one or more identifiable 
stressors 
 
Exhaustion disorderb Physical and psychological exhaustion (> 2 weeks), developed as a 
consequence of prolonged exposure to identifiable stressor(s) (> 6 months) 
Note. Core symptoms according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-5) 11. Although there are some changes in diagnostic criteria from the former version (DSM-IV) 19, core 
symptoms are largely unchanged. aObsessive-compulsive disorder and post-traumatic stress disorder are found 
among obsessive-compulsive and related disorders and trauma and stressor-related disorders, respectively, in 
the DSM-5, but are for conceptual reasons listed among the anxiety disorders in this table. bCriteria according to 
the Swedish version of the International Statistical Classification of Disease and Related Health Problems, tenth 
revision (ICD-10) 12. 
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2.1.2 Processes that maintain common mental disorders 
Although mechanisms that maintain a disorder in some instances differ from treatment 
mechanisms, they are often interchangeable 20. Thus, for effective treatment of CMDs, 
understanding of their maintaining processes is of importance as it gives clues to treatment 
components that could effectively act on these processes. One pragmatic division of 
processes into categories, although not separate entities in reality, can be made using the 
distinction psychological process (e.g., behavioral and cognitive) vs. biological/physiological 
process (i.e., inflammation in the present thesis). These constitute two perspectives, or 
observational levels, in the pursuit of understanding the mechanisms that maintain these 
disorders. In the following, hypothesized maintaining processes of CMDs will be outlined. 
For psychological processes, generic maintaining factors for CMDs will be reviewed briefly, 
but the main focus will be on exhaustion disorder and social anxiety disorder. For 
inflammatory processes, the scope will include all CMDs.  
2.1.3 Maintaining processes - psychological  
2.1.3.1 Generic maintaining factors 
A cognitive-behavioral account of psychiatric disorders is based on learning theory and/or 
cognitive/information processing theory. Following is a brief description of key assumptions.  
From a learning theory perspective, CMDs can largely be understood from classical and 
operant principles. Stimuli functions (e.g., from an unconditioned stimulus) can transfer to 
other stimuli (a conditioned stimulus) due to paring 21. This way, a former neutral stimulus 
can elicit a similar response (conditioned response) as elicited by the unconditioned stimulus 
(unconditioned response). For example, a car accident may cause former neutral stimuli (e.g., 
driving a car, traffic in general, certain sounds, or a particular road) to elicit strong emotional 
reactions, for example intense fear. Further, the conditioned stimulus and response now act as 
antecedents for operant behavior, that is, behavior that is emitted due to its consequences. 
Behavior probability is increased by reinforcement (positive or negative) and decreased by 
punishment (positive or negative) 22. To build on the former example, avoidance of high-
traffic areas or planning the driving route ahead might be strengthened by the effect of 
reducing fear and anxiety (negative reinforcement). This way the behavior has beneficial 
effects in the short term (e.g., decrease in aversive feelings), while the long-term effects are 
that the conditioned stimuli (e.g., driving on busy roads) continues to elicit fear, as extinction 
(presenting the conditioned stimulus without the unconditioned stimulus) is hindered. 
Importantly, avoidance in its various forms impedes value-driven behavior that could provide 
access to positive reinforcement, which can result in long-term consequences for mood. Thus, 
emotional problems can be viewed as acquired through classical conditioning and maintained 
through operant conditioning. Of note, the behavioral principles just described interact with 
language and cognition so that the impact of direct contingencies can be altered (e.g., stimuli 
can be related without actual pairing, as described in relational frame theory, and verbal 
stimuli in the form of instructions/rules can come to compete with direct contingencies) 23. 
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This line of research is gaining support 24, but the following section will rather describe the 
traditional information processing perspective of cognition, which is a central theoretical 
basis for many evidence-based treatments for CMDs.    
According to cognitive theory, maladaptive cognitions are central to the maintenance of 
emotional distress 25. In Beck’s cognitive model of emotional disorders, enduring negative 
beliefs (e.g., about failure and self-worth in depression, and danger/threat in anxiety) lead to 
biased information processing (based on the negative beliefs) which in turn result in negative 
automatic thoughts (i.e., negative and threat-focused thoughts, interpretations and images) 26. 
For example, an important cognitive bias, especially in anxiety disorders, is the 
overestimation of the probability of an aversive event, as well as the overestimation of the 
potential cost of such an event 27. Also, selective attention biased toward negative information 
is found in emotional disorders 28,29. As to behaviors, they have a central role also in cognitive 
theory, although their role is framed differently compared to learning theory. Avoidance, 
escape and safety behaviors (i.e., behaviors intended to prevent feared catastrophes) hinder 
corrective information that could have positive impact on cognitive content 30-32.  
Thus, dysfunctional behaviors and distorted thinking are core units of analyses regarding 
maintenance of mental disorders. These patterns come in several forms, for example 
avoidance of feared stimuli or deficits in relaxing behaviors/skills, or biased thinking that 
involves overestimation of threat or concerns limited confidence in one’s own abilities to 
cope 33. Hypothesized maintaining processes of specific disorders often lean on learning 
theory, cognitive theory, or a combination of the two. The general principles of these theories 
are often detailed to the specific disorder in development and research on maintaining 
processes. Below follows a description of central maintaining factors in exhaustion disorder 
and social anxiety disorder, respectively. The processes outlined for exhaustion disorder are 
mostly consistent with learning theory, while the ones for social anxiety disorder are based on 
a cognitive maintenance model.   
2.1.3.2 Exhaustion disorder 
The present thesis focuses specifically on deficits in recovery as a central factor in the genesis 
and maintenance of stress-related problems 34-36 (although numerous other theories of the 
potentially aversive consequences of prolonged exposure to non-traumatic stressors exist). 
Reactions to exposure to stress do not, in this perspective, constitute a long-term problem as 
long as adequate recovery is present. Recovery refers to psychophysiological unwinding, that 
is, both mental and physiological relaxation 34. Figure 1 is based on the model by Geurts and 
Sonnentag 34, and displays a theoretical model that links stress exposure and potential 
aversive long-term consequences. Exposure to stressful life circumstances or events (only 
referred to as work stress in the original model) activate physiological systems (e.g., the 
sympathetic nervous system and the hypothalamic-pituitary-adrenal [HPA] system) to enable 
effective handling of the stressor at hand 34,37. In the short term, this effort is associated with 
harmless load reactions such as accelerated heart rate and temporary fatigue. However, with 
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incomplete recovery, physiological systems do not stabilize which can result in long-term 
health problems such as chronic fatigue and tension, as well as somatic disease 34.    
 
Figure 1. Model of relations between stressors, load reactions and recovery based on the model by 
Geurts and Sonnentag 34. 
Given the importance of recovery, what factors impede this beneficial process? From a 
learning theory perspective, deficits in recovery (i.e., recuperating behaviors) can be viewed 
as caused by external and internal events that reduce such behaviors, i.e., the absence of 
reinforcers or the presence of punishers 38. For instance, taking breaks at work could be 
followed by both punishment (e.g., comments from colleagues and feelings of guilt) and lack 
of reinforcement (e.g., limited social interaction available), leading to reduced future 
probability of the behavior. This is in line with a behavioral account of depression, which 
emphasize that reinforcement is more readily provided for depressed behavior (in this context 
equivalent to stress-induced, or acute load induced, behavior) than for non-depressed 
behavior (recuperating behavior in the context of stress) 39. Moreover, antecedents of 
recuperative behavior might be largely lacking, i.e., clear environmental triggers for such 
behaviors are absent.  
Further, cognitive factors, such as worry and rumination, can play a central role in prolonging 
physiological activation 40. Worry can be defined as a chain of negative thoughts and images, 
uncontrollable in nature, and concerns mental problem-solving of future events with possibly 
negative outcomes 41. Rumination, in the context of stress, can be defined as negative, 
repetitive and passive focus on stressors and problems 34,40,42. These perseverative cognitions 
(i.e., worry and rumination) can impede psychophysiological unwinding and prolong the 
effect of stressors. In other words, lack of psychological detachment from stressors is an 
important contributor to incomplete recovery 43 and perseverative cognitions have been found 
predictive of exhaustion and fatigue 44,45. From a behavioral perspective, worry and 
rumination can be viewed as verbal behaviors, maintained by both negative and positive 
reinforcement (e.g., being associated with inactivity it reduces exposure to the actual 
problems at hand, and it might be intermittently followed by a feeling of things making 
sense) 38,46.  
Finally, sleep is central to recovery, a fundamental source of deactivation and 
psychophysiological unwinding. Low sleep quality (particularly nonrestorative sleep and 
Stressful 
circumstances and 
events 
Acute load 
reactions
Chronic load 
reactions 
Recovery
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trouble falling asleep) have been found associated with poor recovery, which in turn relates to 
level of exhaustion 47. Also, insufficient sleep may predict future exhaustion 36, and sleep 
disturbance is a common feature in exhaustion disorder 14,48. Thus, sleep disturbance seems to 
be an important factor in both the development and maintenance of exhaustion. Importantly, 
a factor contributing to sleep disturbance in stress is perseverative cognitions 43.        
2.1.3.3 Social anxiety disorder 
Several models that detail key cognitive and behavioral factors central in the maintenance of 
social anxiety disorder (SAD) exist 49-52. These models are all relatively consistent and 
emphasize the same main processes including negative social-evaluative cognitions, 
attentional bias, avoidance and safety behaviors, and anticipatory and post-event processing 
53. Findings of systematic reviews shows empirical evidence for the importance of these 
processes in the maintenance of SAD 53-56.  
Presumably the most influential and empirically supported model of maintaining processes in 
SAD is the cognitive model of Clark and Wells published in 1995 52. The model is displayed 
in Figure 2 (for clarity, not all causal arrows are depicted) and stipulates the following 52,57,58: 
When an individual with SAD enters a social situation, negative beliefs are activated. These 
consist of negative assumptions about themselves and the social environment, and 
specifically revolve around acting in an unacceptable way that will lead to catastrophic 
consequences. This leads to a perception of social danger/threat (negative automatic 
thoughts) that triggers anxiety, including somatic and cognitive symptoms. Further, four 
processes are outlined that maintain negative beliefs and social anxiety. First, perception of 
social danger results in a shift to self-focused attention and the individual starts to monitor 
and observe herself, with a corresponding decrease in observation of the social environment. 
This initiates what is referred to as ‘processing of self as social object’. Second, and as a 
consequence, interoceptive information is used to make inferences about the impression made 
on others, often resulting in excessively negative self-judgements. Thus, the individual uses 
anxious feelings and distorted images to create an impression of how she appears to others. 
Third, safety behaviors, both overt and covert, are used to prevent feared outcomes and 
reduce the risk of negative evaluation. However, they result in maintained negative beliefs, 
and increase feared symptoms as well as self-focused attention. Fourth, although not 
explicated in the graphic model, anticipatory and post-event processing (i.e., worry and post-
mortem rumination) are emphasized as important maintaining factors for social anxiety. 
Worry about an upcoming social event puts the individual in an anxious and self-focused 
mode, which reduces the likelihood of noticing being accepted by others. It can also lead to 
avoidance of the situation altogether. Post-mortem rumination means to review a social 
situation in detail after the event, and includes using interoceptive information to infer 
performance, which (again) results in an overly negative evaluation. 
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Figure 2. Cognitive model of social anxiety disorder according to Clark and Wells 52. 
An interesting addition to the original model concerns that the content and meaning of 
negative and distorted self-images, a key factor in the maintenance of SAD, may be linked to 
memories of socially traumatic events 59,60. Thus, adverse social experiences (e.g., being 
bullied by peers) may be involved in the development of negative images (distorted 
witnessing the self from an observer’s perspective), which are activated in later social 
situations. In some current versions of the model, early experiences have been added as a 
factor affecting self-focus and image/impression 61. 
2.1.4 Maintaining processes - inflammatory  
In addition to what can be termed psychological factors, investigation of biological processes 
that potentially contribute to, and maintain, CMDs can give additional information on how to 
relieve symptoms. During the past decades, immune dysregulation, and specifically 
inflammatory markers such as pro-inflammatory cytokines, has gained scientific interest as a 
factor involved in mental disorders.  
2.1.4.1 Immune-to-brain communication 
Pro-inflammatory cytokines are proteins that act as messengers in the immune system and 
coordinate local and systemic inflammation. They also communicate about bodily states to 
the brain through humoral and neural pathways 62. This way, immune activation can induce 
the so called “sickness response”, a motivational state that promotes recovery, including loss 
of appetite, depressed mood, anxiety, sleepiness, increased pain sensitivity, withdrawal from 
social activities, and fatigue 63,64. Experimentally, when lipopolysaccharide (endotoxin) is 
administered to healthy individuals (to mimic a real bacterial challenge) a transient 
inflammatory response is induced and symptoms of the sickness response are displayed 64,65. 
In the face of immunological challenges (e.g., bacteria, viruses and parasites), this response 
promotes adaptive behavioral changes (e.g., triggers resting and limits exposure to additional 
Social situation
Activates assumptions
Perceived social danger 
(negative automatic thoughts) 
Safety behaviors
Somatic and cognitive 
symptoms
Self-focus and 
image/impression
Early 
experiences
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pathogens). However, when inflammation is elevated over prolonged periods, the sickness 
response might be maladaptive. Pro-inflammatory cytokines can impact serotonin, 
norepinephrine and dopamine, important regulators of affect 66, and when chronically 
elevated contribute to symptoms central to CMDs. Although not clearly established, possible 
sources of low-grade inflammation are psychosocial stress, physical inactivity, poor diet, 
smoking, obesity, altered gut permeability, disturbed sleep and vitamin D deficiency 67.   
2.1.4.2 Brain-to-immune communication 
Importantly, the immune-brain relation is bidirectional, i.e., the brain also communicates to 
the immune system. For example, threat (or perceived threat) activates the fast sympathetic 
pathway and the relatively slower hypothalamic–pituitary–adrenal (HPA) pathway. This 
results in secretion of norepinephrine, epinephrine and cortisol, neurotransmitters and 
hormones that the immune system express receptors for 68. Thus, psychological challenges 
can, as well as pathogens, impact the immune system. A recent meta-analysis investigated the 
effects of acute laboratory stress on inflammatory markers 69. Results showed that 
psychological stress (e.g., induced by social evaluative threat or a difficult puzzle task) lead 
to significant increases in inflammatory markers (although large variability between 
individuals was found). Equally, prolonged exposure to stressors can affect and dysregulate 
the immune system 70.  
2.1.4.3 Inflammation in common mental disorders 
Chronic low-grade elevations of inflammatory markers might be one physiological factor 
contributing to symptoms in CMDs. The association between CMDs and inflammation has 
especially been studied with regard to depression. Several meta-analyses of cross-sectional 
associations have found elevated inflammatory markers in depressed patients compared to 
healthy controls 71-73. For anxiety, a recent meta-analysis found inflammatory markers to be 
elevated in people with anxiety disorders, including post-traumatic stress disorder and 
obsessive-compulsive disorder, compared to healthy controls 74. However, this difference was 
accounted for by post-traumatic stress disorder (i.e., no associations were found in the 
remaining disorders, however examined with lower statistical power). Consistently, a 
previous meta-analysis of post-traumatic stress disorder found elevated inflammatory 
markers compared to healthy controls 75, while results for other anxiety disorders are mixed 
76-78. A meta-analysis on sleep disturbance found associations with elevated inflammatory 
markers 79. For stress-related symptoms of burnout, elevated inflammatory markers have 
been found compared to controls 80, but there are also negative findings 81,82. 
The causal relation between emotional symptoms and inflammation is yet to be elucidated. 
For example, a meta-analysis of longitudinal studies found small but significant associations 
between inflammatory markers and subsequent depressive symptoms 83, but studies also 
support that depressive symptoms predict subsequent changes in inflammatory markers 84. 
Given the bidirectional communication between the central nervous system and immune 
system, effects might be reciprocal. Nonetheless, inflammatory activity might be a 
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physiological process that contribute to CMDs, and symptomatic improvement following 
effective treatment might involve changes in inflammatory processes.   
2.2 COGNITIVE BEHAVIOR THERAPY (CBT) AND CHANGE PROCESSES IN 
COMMON MENTAL DISORDERS 
2.2.1 Effectiveness of CBT  
Cognitive behavior therapy (CBT) is an umbrella term that includes a variety of treatments 
based on cognitive and/or learning theory, that share a common focus on the relations 
between thought, behavior and emotion. Due to the extensive empirical study of its 
effectiveness, CBT is argued to be the gold standard of psychotherapies 85. Meta-analyses of 
randomized controlled trials have shown face-to-face CBT to be effective/efficacious, 
yielding large effect sizes, for anxiety disorders 86-92, depression 93 and insomnia 94,95. Also, 
CBT delivered as guided self-help has shown to be efficacious for these disorders 96-98. For 
stress-related disorders the evidence base for CBT is less convincing than for other CMDs. 
For work-related stress, a synthesis of systematic reviews found CBT to produce larger 
effects than other interventions 99. However, meta-analyses of diagnosed samples have failed 
to find superior improvements of CBT compared to control conditions for both adjustment 
disorder 100 and exhaustion disorder 101. Although recent randomized trials have found 
promising results of CBT for these disorders 102,103, the effectiveness of CBT remains 
uncertain. 
Important from a dissemination perspective, stepped care models have been suggested as a 
viable solution to increase access to evidence-based psychological treatments 10. In such 
models, patients are first offered a low-intensity treatment (e.g., guided self-help, requiring 
less time from the professional) and those patients who do not respond are stepped up to 
treatment of higher intensity (e.g., face-to-face treatment) 104. However, results of previous 
research on stepped care models for CMDs have been mixed 104-109, and it is still unclear 
whether patients who do not respond to guided self-help CBT would benefit from face-to-
face CBT. 
Moreover, effects of CBT for CMDs have most commonly been evaluated with regard to 
symptom improvements. Outcomes focusing on function, such as reductions in sick leave 
following CBT, have been investigated but to a lesser extent. A recent meta-analysis found 
that psychological interventions, including CBT, significantly reduced sick leave, but that 
effect sizes were small 110. There was no significant difference in effect between the 
interventions that were compared to care as usual in this meta-analysis, e.g., return-to-work 
interventions (RTW-I) that had a clear work-focus and interventions that mainly focused on 
symptom reduction (e.g., CBT) produced similar effects on sick leave.    
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Further, even though CBT produces significant improvements in symptoms, a substantial 
proportion of patients are not sufficiently helped. For anxiety disorders, reviews have found 
that between a third and half of patients were classified as non-responders at post-treatment 
111,112. For depression, we showed in a recent meta-analysis of CBT in primary care that 
although CBT was more effective than control conditions, 51% of patients were classified as 
non-responders post-treatment 113.  
In sum, even though CBT is very helpful for many patients, there are several areas that could 
be improved. Aside from issues concerning delivery models that can increase accessibility 
and questions concerning how return to work from sick leave can be ameliorated, there is also 
room for considerable improvements in symptom reduction. Investigation of mechanisms of 
change in CBT for CMDs is one important way to enhance treatments effects. As of today, 
we know little about how change comes about in CBT, hindering optimal treatment delivery.   
2.2.2 Mechanisms of change  
What changes unfold during CBT that lead to improvement? One crucial way of enhancing 
CBT’s effectiveness is to increase knowledge of treatment mechanisms. Mechanisms in this 
context refer to the basis of the effect of CBT, that is, the chain of events or processes that 
explain how therapeutic change comes about 114. In essence, key treatment components (i.e., 
the active ingredients) lead to enduring changes in mechanisms (e.g., cognitions or 
behaviors), which in turn lead to some beneficial outcome (i.e., the goal of treatment, e.g. 
reduction in anxiety or increased function) 115,116. Identifying change mechanisms is vital for 
treatment development and gives information on how to optimize key treatment components 
20. Also, research on mechanisms can provide suggestions on how to streamline treatments, 
by removing ineffective components from the treatment protocol. For the clinician, this 
revolves around the critical question of what should be said and done to maximize the 
probability of effectively helping the patient. A better understanding of mechanisms can also 
help to discover moderators of treatment outcome (i.e., characteristics that affect the relation 
between an intervention and outcome) which concerns matching patients with treatment to 
improve benefit 20,117. 
Although change mechanisms are far from fully elucidated for any psychiatric disorder 20,114, 
knowledge from different scientific approaches (e.g., experimental and observational research 
on psychopathological processes) continuously contribute with small pieces of the puzzle. 
One essential area of research in this respect is the study of processes and mediators in the 
context of clinical trials. A mediator is a variable that statistically explains the relationship 
between an independent variable (e.g., treatment) and a dependent variable (e.g., anxiety) 114. 
Baron and Kenny 118 introduced a path diagram to depict the causal chain involved in 
mediation, as well as an analytic strategy to establish mediation. The diagram is displayed in 
Figure 3. 
  13 
 
Figure 3. Mediation model by Baron and Kenny 118.  
Baron and Kenny suggested that a variable function as a mediator when the following criteria 
are met: (1) the independent variable affects the mediator (i.e., the a-path), (2) the mediator 
affects the dependent variable (i.e., the b-path), and (3) the previously significant effect of the 
independent variable on the dependent variable (i.e., the c-path) is reduced or eliminated 
when controlling for the mediator (i.e., paths a and b). Although seminal, the analytic 
procedures proposed by Baron and Kenny have received criticism (e.g., concerning that 
significant mediation can exist even in the absence of a significant c-path) and alternative 
methods have been recommended 119. Nevertheless, the conceptual aspects of investigating 
the respective causal paths are still relevant.  
In clinical trials, investigation of pre-to-post changes in proposed processes and outcome can 
be a first step to look for associations that might give suggestions for future research. 
However, a vital criterion for a mediator is that it precedes outcome. The influential article by 
Kazdin from 2007 114 highlights evaluation of a timeline, i.e., the temporal precedence 
criterion. This concerns the above described b-path, i.e., the effect of the mediator on the 
outcome. Both potential processes/mediators and outcome need to be assessed at several 
times during treatment to answer the crucial question of the temporal relations between 
changes in mediator and outcome. Of note, a statistically established mediator gives clues to 
mechanisms of action, but does not necessarily mean that a mechanism has been revealed, 
i.e., the mediator could be a proxy for another variable 117. As argued by Kraemer and 
colleagues, “all mechanisms are mediators, but not all mediators are mechanisms” 120 (p. 878). 
Further, a mediator might give some explanation of how change came about, but leave much 
more to be investigated. For example, finding that self-efficacy mediates improvements in 
anxiety does not explain how change in self-efficacy leads to that change (i.e., multiple other 
processes could be involved) 20. Nevertheless, a mediator points the direction for future 
inquiries and the study of processes and mediators in clinical trials is a step towards 
understanding mechanisms of change. 
2.2.3 CBT and psychological change processes  
2.2.3.1 Key treatment components in CBT and proposed mechanisms 
Simplified, CBT components can broadly be categorized as behavioral (e.g., behavioral 
activation and exposure) or cognitive (e.g., cognitive restructuring and behavioral 
experiments) based on their supposed target. Although sometimes used in isolation, several 
components are often incorporated in treatment packages, including psychoeducation on the 
Independent variable 
(treatment)
Dependent variable
(outcome)
Mediator
a b
c
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nature of core symptoms; behavioral activation; exposure; cognitive restructuring; behavioral 
experiments; safety behavior manipulation; relaxation; and response and relapse prevention 
121. In the following, a short description of four key components related to presumed change 
processes is outlined. 
Behavioral activation, originally designed for treatment of depression, is based on the 
assumption that insufficient positive reinforcement is the cause of depressed mood 122. 
Correspondingly, behavioral activation is a reinforcement-based treatment, aiming to reduce 
avoidance and increase activation to access positive reinforcement and consequently improve 
mood  38,123. Given the recurrent reduction in goal-directed and pleasant activities across 
mental disorders, it has been suggested that rather than constituting a treatment for 
depression, behavioral activation should be a broadly integrated part in psychotherapy 124. 
Exposure refers to the systematic approach to feared stimuli. Depending on the feared stimuli, 
exposure can be categorized in vivo (i.e., approach to a real-life situation, such as public 
speaking for a person with social anxiety disorder), imaginal (e.g., memory work in post-
traumatic stress disorder), or interoceptive (e.g., exposure to feared bodily sensations in panic 
disorder). The mechanism by which exposure exert its effects on anxiety/fear is suggested to 
be fear extinction: the conditioned stimulus is faced repeatedly in the absence of the 
associated aversive event (i.e., the unconditioned stimulus) 125. Previously, habituation (i.e., 
fear reduction during exposure) was thought a necessity for fear extinction, but a more 
modern view rather stresses the importance of inhibitory learning (although habituation might 
still be involved) 125,126. Inhibitory learning means that the therapeutic goal is not to eliminate 
the association between the conditioned and unconditioned stimulus during exposure. Rather, 
new learning comes to compete with it (i.e., that the conditioned stimulus no longer predicts 
the unconditioned stimulus) 125. Thus, the conditioned stimulus now has two meanings (i.e., 
one that can elicit fear, and one signaling safety).  
Cognitive restructuring is a treatment component that aims to (a) identify key maladaptive 
beliefs and thoughts central to emotional distress, and (b) evaluate and challenge them to 
generate more adaptive and functional thinking patterns 26. Its proposed mechanism of 
change is that changes in biased information processing and negative thinking is responsible 
for reductions in emotional symptoms. In other words, cognitive reappraisal is the core 
process believed to be affected by this strategy, and subsequently have impact on symptoms.       
Behavioral experiments refer to confrontation with anxiety-provoking situations to test 
whether feared outcomes actually occur 58. Safety behaviors are dropped and focus of 
attention is directed to maximize disconfirmation of negative predictions 57. Behavioral 
experiments draw on information-processing theory and can be viewed as an extension of 
cognitive restructuring 127. Behavioral experiments overlap with exposure, especially within 
its inhibitory learning framework, but differences between the two have been outlined, for 
example the testing of explicit cognitions in the former 125.  
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Given that treatment protocols often include several components, elucidation of component-
mechanism-outcome relations is generally difficult. Even in cases where treatments have 
distinct components that link to suggested mechanisms, the proposed causal pathways are not  
always supported by empirical data. There are some influential studies that have contributed 
with important knowledge in this regard. For example, a component-analysis of depression 
treatment randomized patients to (a) behavioral activation, (b) behavioral activation + work to 
modify automatic thoughts, or (c) behavioral activation + work to modify automatic thoughts 
+ focus on core schemas 128. Results showed there was no difference between treatments in 
outcomes (i.e., depressive symptoms and diagnostic status), and importantly, they all 
produced similar changes in maladaptive cognitions. As suggested in a review evaluating 
mechanisms of change in treatment of depression, cognitive changes seem to mediate 
therapeutic improvement, but changes in cognition might not be specific to cognitive 
interventions 129. Thus, what might intuitively seem to be related (e.g., cognitive restructuring 
and cognitive change), could in fact also involve other causal routes (e.g., behavioral 
activation and cognitive change).  
In the following three sections, I will describe processes potentially relevant for treatment 
outcome in more detail within three different areas: (a) psychological change processes in 
CBT for exhaustion disorder, (b) psychological change processes in CBT for social anxiety 
disorder, and (c) inflammatory correlates in CBT for CMDs broadly.  
2.2.3.2 Change processes in CBT for exhaustion disorder 
No evidence-based treatments exist for exhaustion disorder (ED). The treatment protocol 
used in the present thesis was developed by our research group, and is based on a model 
highlighting deficits in recovery, particularly recuperating activities but also associated with 
sleep, as central maintaining factors of exhaustion 34-36.  
Treatment content is displayed in Table 2. It includes several typical CBT components. 
Behavioral activation is a central focus in treatment, based on the protocol by Lejuez and 
colleagues 123. It includes all parts of the original protocol (monitoring of activities and mood 
states, identification of values and specific activities in accordance with values, prioritizing 
among activities, activity scheduling, and evaluation of consequences of behaviors/activities) 
but places a specific focus on increasing activities that serve a recuperating function. For 
example, concerning monitoring of activities and their consequences, patients not only rate 
pleasure and importance of activities, but also recuperating effects. Thus, in addition to its 
original focus on alleviating depression, the behavioral activation component in the present 
protocol aims at increasing recovery, presumably by frequently inducing relaxation both 
mentally (e.g., slow thoughts down) and physiologically (e.g., decreased arousal). The 
behavioral activation component is present in every session of treatment as well as in 
homework exercises. Additionally, a brief relaxation exercise is taught to patients early in 
treatment as a specific activity for recovery, and frequent use is encouraged.  
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Increased recovery from sleep may be vital for exhaustion improvement 47. Strategies to 
enhance sleep quality were included in treatment if deemed meaningful to the specific 
patient. These strategies includes both specific components (such as limiting time in bed and 
adhering to scheduled sleep times) and more indirect approaches that also could be part of the 
behavioral activation (such as increasing light exposure, physical activity and daytime 
relaxation). The treatment also includes functional analyses and exposure, as anxiety (and 
associated fear-avoidance patterns) is common in ED 14. 
Table 2. Session content and homework exercises of cognitive behavior therapy for 
exhaustion disorder 
Session Main focus of session Main homework 
1 Psychoeducation about stress, 
exhaustion disorder and CBT 
Monitoring of activities; idiosyncratic model of 
development of exhaustion  
 
2 Recuperating activities, brief 
relaxation technique 
Monitoring of activities; planning of recuperating activities  
 
 
3 Life areas, values and activities Monitoring of activities; planning of recuperating activities; 
register values and activities 
 
4 Life areas, values and activities Monitoring of activities; planning of recuperating activities; 
register values and activities, and prioritize among activities 
 
5 Scheduling of activities (recuperating 
and according to values) 
Activity scheduling and monitoring 
 
 
6 Emotion-driven behaviors, functional 
analysis and exposure 
Activity scheduling and monitoring; functional analyses 
 
 
7 Emotion-driven behaviors, functional 
analysis and exposure 
Activity scheduling and monitoring; functional analyses 
 
 
8-10 Optional: sleep, communication skills 
or dysfunctional assumptions 
Activity scheduling and monitoring; functional analyses; 
according to chosen component 
 
11 Relapse prevention Action plan 
Note. Treatment was scheduled for 9 to 13 weekly sessions. CBT = cognitive behavior therapy. 
Although it is theoretically reasonable to target recovery, research on processes and mediators 
of change in CBT for stress and burnout generally, and ED specifically, is scarce. 
Consequently, there is limited knowledge regarding crucial processes of change in ED. 
However, a few trials give clues to potential process targets.  
One trial, consistent with the theoretical model put forth earlier, investigated the effects of a 
recovery-focused program 35. Participants with stress-related complaints took part in a group-
based intervention that focused on increasing behaviors with recuperating effects. Relaxation 
training was also included in the program. Main findings were that frequency of recovery 
behaviors increased, while perceived stress, anxiety, depression and exhaustion decreased. 
Further, changes in frequency of recovery behaviors, as well as worry, predicted symptom 
change. Although results were promising, some methodological limitations (e.g., that the trial 
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was not randomized and that assessments were only conducted pre- and post-treatment) 
hinder conclusions regarding both effects on outcome and presumed change processes.   
Another study relevant to the presumed importance of recovery investigated teachers with 
sleeping problems and work-related strain 43. Participants were randomized to an internet-
based recovery intervention or waitlist control condition. The intervention primarily focused 
on promoting restorative behavior, but also included specific sleep-enhancing strategies and 
meta-cognitive techniques to target perseverative cognitions. An important finding was that 
increased number of recuperating activities was associated with reductions in perseverative 
cognitions, which in turn was associated with improvements in sleep. Of importance for 
causal claims, assessments of mediators (recovery behaviors and perseverative cognitions) 
and outcome (insomnia severity) were not repeated throughout the treatment period.  
In a study by Ebert and colleagues 130, employees with elevated symptoms of perceived stress 
were randomized to a CBT-based intervention delivered via the internet or a waitlist control 
group. The intervention consisted of problem-solving, relaxation and emotion regulation 
techniques. In a pre-to-post mediational analysis, a significant indirect effect of emotion 
regulation on perceived stress was found in the intervention group relative to the waitlist. In 
line with the authors’ description of limitations, other potential mediators were not measured 
and the mediator as well as outcome were not measured during treatment. 
Another study randomized participants (a non-clinical sample at risk of strain and burnout) to 
a group-based CBT intervention (acceptance and commitment therapy) or a waiting list 
control group 131. Assessments were completed at baseline, mid- and post-treatment and at six 
months follow up. Results showed that decrease in emotional exhaustion between mid-
treatment and follow up was mediated by increase in psychological flexibility (i.e., the ability 
to focus in the present and move towards goals/values even when aversive thoughts or feeling 
are present) mid-treatment to post-treatment in the treatment group relative to the control 
condition.  
In sum, there is to date limited research on potential processes/mediators of change in stress 
and burnout. Current studies have focused on elevated symptoms, but none have investigated 
clinical samples. Further, studies have typically not used repeated measures of mediators and 
outcome during treatment, hampering conclusions regarding temporal precedence. In the 
context of limited knowledge of how change unfolds in ED, generic processes (i.e., relevant 
across treatments and disorders) have been suggested to be important for symptom 
improvement. Two such processes, perceived competence and therapeutic alliance, might 
also be pertinent in CBT for ED. Perceived competence refers to an individual’s belief in the 
ability to cope 132. Therapeutic alliance refers to the working collaboration between patient 
and therapist 133. Both these processes might be related to behavior change, but might also 
influence outcome on their own 132,134. 
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2.2.3.3 Change processes in CBT for social anxiety disorder 
CBT targets the presumed maintaining factors of social anxiety disorder (SAD) in several 
ways, aiming to achieve decreases in a variety of judgmental biases, self-focused attention, 
and avoidance and safety behaviors. The self-help treatment used in the present thesis 135 
consist of components typically included in CBT protocols for SAD. Treatment components 
map to the presumed maintaining processes and include, for example, challenging evidence 
of NATs and behavioral experiments to correct negative social-evaluative cognitions, 
dropping of safety behaviors, practice in shift of attention to promote reduction in attentional 
biases, and exposure exercises to break patterns of avoidance as well as maintenance of fear-
associated stimuli. Treatment content is displayed in Table 3. 
Table 3. Session content and homework exercises of self-help cognitive behavior therapy for 
social anxiety disorder  
Chapter Main focus of the chapter  Main homework 
1 Psychoeducation about SAD, CBT and 
self-help treatment 
 Self-screening for SAD 
 
 
2 Thoughts in social anxiety and the 
cognitive model of SAD by Clark and 
Wells 52 
 Self-monitoring of NATs and idiosyncratic model 
of SAD 
 
 
3 Thinking errors and challenging thoughts  Self-monitoring of NATs and anxiety-triggered 
behaviors; challenging evidence for negative 
thoughts; goal-setting 
 
4 Challenging thoughts through behavioral 
experiments 
 Behavioral experiments 
 
 
5 Rationale for exposure  Establishing an anxiety hierarchy; exposure 
exercises  
 
6 Focus of attention and manipulation of 
safety behaviors 
 Practice in shift of attention; behavioral 
experiments with and without safety behaviors 
 
7 Problem-solving revolving exposure 
exercises 
 Continued exposure exercises, with additional 
attention on safety behaviors 
 
8 Social skills in relation to previous 
avoidance 
 Assertiveness-training 
 
 
9 Relapse prevention  Action plan including key learning from each 
chapter; goal evaluation 
Note. Although not the main theme of any specific chapter, anticipatory and post-event processing is also 
covered in the treatment. SAD = social anxiety disorder; CBT = cognitive behavior therapy; NATs = negative 
automatic thoughts.  
Several clinical trials of CBT have investigated the proposed maintaining factors according to 
the cognitive model of SAD as change processes. However, a majority of studies have used 
pre-post (or pre-mid-post) designs that impose limitations regarding causal inferences of 
process-outcome relations. Nevertheless, these studies provide valuable information insofar 
that CBT seem to reduce negative social-evaluative cognitions, self-focused attention, 
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avoidance, and safety behaviors, and that changes in these processes are related to outcome 
136-144. Thus, prior research support that CBT for SAD affects the outcome (i.e., the c-path in 
a traditional mediational analysis) and processes (i.e., the a-path), and that processes 
statistically account for change in the outcome (i.e., the mediated/indirect effect).  
In addition, a few studies have used designs that fulfill one of the key criteria for the 
mediational b-path, namely temporal precedence, i.e., whether change in the processes occur 
before change in outcome 145-150. In these studies, repeated assessment of processes and 
outcome during treatment has enabled analytic methods to investigate the timeline of change 
in CBT for SAD. An effect on subsequent social anxiety has been found for negative 
cognitions 150, overestimated probability and cost of negative social events 145,149, self-focused 
attention 145-147, avoidance 146,148, safety behaviors 145, and anticipatory and post-event 
processing 146. Of note, the studies that also analyzed the possibility of a reversed direction of 
effects (i.e., reductions in social anxiety predicting subsequent changes in the presumed 
processes) found support for this claim regarding several of the investigated processes 145,147-
149. An illustrating example comes from the analysis by Hoffart and colleagues 145. In this 
study, cognitive therapy for SAD resulted in a unidirectional effect of reductions in safety 
behaviors on subsequent reductions in social anxiety. However, the remaining processes 
investigated (i.e., self-focused attention, estimated probability and cost) predicted subsequent 
social anxiety, but were also predicted by prior reductions in social anxiety. Thus, a 
reciprocal relationship between the presumed processes of change and social anxiety has been 
found in previous research, and the true role of these processes is yet to be established. 
Importantly, limited evidence is available for the notion that changes in the proposed 
processes are responsible for reductions in social anxiety, and not vice versa. To streamline 
CBT for SAD, enhance its effectiveness and develop new treatment approaches, such 
information is vital.  
2.2.4 CBT and inflammatory processes 
Inflammatory processes, and specifically elevated levels of pro-inflammatory cytokines, 
might contribute to CMDs. Reversing this dysregulation could be part of symptom 
improvements following CBT. For example, cognitive and behavioral strategies could affect 
inflammatory markers through changes in HPA-axis and sympathetic activity 151. For 
instance, reducing anxiety through exposure might affect sympathetic pathways that have 
impact on immune activity. More indirectly, CBT could impact potential sources of low-
grade inflammation, such as diet and physical activity 67. Increased knowledge on 
physiological aspects of therapeutic change could offer insights to the potential benefit of 
novel treatment approaches (e.g., anti-inflammatory medication for depression 152, or CBT in 
conjunction with exercise 153).  
To the best of my knowledge, seven studies have investigated the potentially anti-
inflammatory effects of CBT in CMDs 151,153-158 (not including studies where patients had 
comorbid somatic conditions). Although designs vary across studies, symptoms and 
inflammatory markers were measured pre- and post-treatment in all of them. The specific 
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inflammatory markers measured differ between studies: interleukin-6 (IL-6) and C-reactive 
protein (CRP) were the most commonly assessed, followed by tumor necrosis factor alpha 
(TNF-α) and IL-8. 
Five studies focused on depressive disorder. They all included measurement of  IL-6 pre- and 
post-treatment. In three of the studies, IL-6 was significantly decreased after CBT 154,156,159, 
but did not change in two 151,153. CRP was assessed in three studies and deceased significantly 
in one 159, but not in the other two 151,153. TNF-α was assessed in two studies, and decreased 
significantly after CBT in both 156,159. Further, three of the five studies also investigated if a 
reduction in inflammatory markers was associated with a reduction in depressive symptoms. 
Such a correlation was found in two of the studies 151,154, while no significant relationship was 
found in one 156. For insomnia, one study showed that CBT reduced systemic inflammation 
(measured by CRP) compared to a control condition 157. Further, decreased CRP was 
associated with remission of insomnia at the follow-up 12 months post-treatment 157. One 
study investigated inflammatory markers (IL-6, IL-8 and CRP) in CMDs broadly (depression, 
anxiety and stress-related disorders) 158 and none of the markers were reduced following 
treatment.   
In sum, results as to the potentially anti-inflammatory effects of CBT for CMDs are 
inconclusive. The findings of a recent meta-analysis, including studies on both CMDs and 
somatic conditions, confirm that there are inconsistencies between studies: in 14 of 23 studies 
at least one inflammatory marker was reduced following CBT, while in the remaining nine 
studies levels were unchanged or increased 160. Thus, the role of inflammation in CBT for 
CMDs needs further investigation. Particularly, studies on diverse samples of patients with 
CMDs are largely lacking.   
2.3 SUMMARY  
Because of its strong research support, CBT has a prominent position among psychotherapies 
in the treatment of CMDs. Nevertheless, there is considerable room for treatment 
improvement. More knowledge about processes at work might lead to more effective and 
streamlined treatment. Exhaustion disorder and social anxiety disorder are two highly 
prevalent CMDs, but how change comes about in CBT for these disorders is to a large extent 
unknown. Moreover, inflammatory processes might be involved in symptomatic 
improvement across CMDs, but prior research is limited. Building on two large scale clinical 
trials of CBT for primary care patients, this thesis attempts to add pieces to the filling of these 
gaps of knowledge. 
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3 AIMS OF THE THESIS 
Study I and II are effectiveness trials of CBT in a primary care setting. For the purpose of the 
present thesis, the treatment effects on symptoms found in these two clinical trials constitute 
the base for investigating processes and correlates of therapeutic change, the focus of Study 
III, IV and V.  
STUDY I:  The aim of Study I was to evaluate the effectiveness of three interventions: 
 CBT, a return-to-work intervention (RTW-I), or a combination of the two 
 (COMBO), on psychiatric symptoms and sick leave for primary care patients 
 on sick leave due to CMDs. We hypothesized that CBT (alone or in the 
 COMBO-intervention) would result in significant between-group effects on 
 psychiatric symptoms compared to RTW-I. We also hypothesized that RTW-I 
 (alone or in the COMBO-intervention) would generate significant between-
 group effects on sick leave compared to CBT.  
STUDY II:  The aim of Study II was to investigate a stepped care model for primary care 
 patients with CMDs. In step 1, all patients received guided self-help CBT. In 
 step 2, the additive effect of face-to-face CBT, compared to continued guided 
 self-help CBT, was evaluated for patients not in remission after step 1.We 
 hypothesized that approximately 50% of the patients would be in remission 
 after guided self-help CBT in step 1. Further, we hypothesized that stepping up 
 treatment intensity to face-to-face CBT would result in superior improvements 
 compared with patients receiving continued self-help CBT in step 2. 
STUDY III:  The aim of Study III was to investigate mediators of change in CBT, relative to 
 RTW-I, for exhaustion disorder (patients with at primary exhaustion disorder in 
 Study I were analyzed). We had no a priori hypotheses concerning significant 
 mediators due to limited prior research.    
STUDY IV:  The aim of Study IV was to investigate processes of change in patients with 
 social anxiety disorder receiving guided self-help CBT (patients with a primary 
 social anxiety disorder in Study II were analyzed). We hypothesized that 
 improvements in the maintaining processes according to the cognitive model of 
 social anxiety would predict subsequent improvements in social anxiety.  
STUDY V:  The aim of Study V was to investigate inflammatory markers in patients with 
 CMDs: at baseline and after CBT (patients from Study I and II were included). 
 We hypothesized that higher level of inflammation would correlate to more 
 severe psychiatric symptoms at baseline. We also hypothesized that 
 inflammatory markers would decrease after CBT, and that this reduction would 
 correlate to symptom improvement. 
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4 THE EMPIRICAL STUDIES 
The distribution of patients’ primary disorders in the clinical trials (Study I and II) guided the 
choice of disorders to focus on for further analyses of psychological change processes (Study 
III and IV), as putative process variables were specific for each disorder. The distribution of 
primary disorders among patients in the studies is displayed in Table 4. Exhaustion disorder 
(Study III) was the only suitable diagnosis to analyze from Study I. The choice to focus on 
social anxiety disorder (Study IV) was based on the sample size in Study I, and that process 
measures were judged to be of particular high quality for this disorder. Inflammatory markers 
(Study V) were analyzed across both clinical trials, irrespective of primary disorder.  
Table 4. Primary disorder/problem area for patients in Study I-V, expressed as number of 
patients 
Disorder Study I Study II Study III Study IV Study V 
Exhaustion disorder 125 27 82  108 
Major depressive disorder 27 78   59 
Adjustment disorder 27 85   66 
Generalized anxiety disorder 10 69   49 
Post-traumatic stress disorder 7  -    5 
Social anxiety disorder      6 64  61 39 
Panic disorder  4 36   18 
Obsessive-compulsive disorder 3 8   5 
Insomnia 2 29   18 
Total 211 396 82 61 367 
Note. Specific phobia was not the primary disorder in any case, and is therefore not included in the table.  
For the purpose of the present thesis, Study I and II will be described with emphasis on 
aspects relevant to Study III-V (e.g., long-term treatment effects will not be described here). 
Also, as methods and results are thoroughly described in the respective papers (Study I-V), I 
will only describe them briefly here.  
4.1 STUDY I: COGNITIVE-BEHAVIOURAL THERAPY AND RETURN-TO-WORK 
INTERVENTION FOR PATIENTS ON SICK LEAVE DUE TO COMMON 
MENTAL DISORDERS: A RANDOMISED CONTROLLED TRIAL 
4.1.1 Methods 
4.1.1.1 Procedure and inclusion 
Consecutively recruited adult patients (N = 211) from four primary clinics were randomized 
to cognitive behavioral therapy (CBT), a return-to-work intervention (RTW-I), or a 
combination of the two (COMBO). Main inclusion criterion was that patients were on a 
current sick leave due to a CMD (i.e., social anxiety disorder, panic disorder, generalized 
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anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, major 
depressive disorder, insomnia, adjustment disorder, or exhaustion disorder). 
4.1.1.2 Primary outcomes 
Primary outcomes were (a) psychiatric symptom severity on principal disorder measured by 
the 0-8 scored clinician-administered Clinician’s Severity Rating (CSR) 161, and (b) sick-
leave status, collected from the registry of the Swedish social insurance agency, 12 months 
after start of treatment.  
4.1.1.3 Treatments 
The CBT condition consisted of available evidence-based disorder-specific protocols, applied 
for the patients’ principal disorder. The specific protocols were: cognitive therapy for social 
anxiety disorder 57, panic disorder 162 and post-traumatic stress disorder 163; applied relaxation 
for generalized anxiety disorder 164, exposure with response prevention for obsessive-
compulsive disorder 165; behavioral activation for depression 123; CBT for insomnia 166; and 
an unpublished protocol, developed by the research group, for adjustment disorder and 
exhaustion disorder (described in the background of this thesis).  
The RTW-I condition aimed specifically at helping the patient back to a sustainable work 
situation. The treatment was developed by the research group, influenced by previous 
research suggesting that sick-leave issues should be addressed early in treatment, that the 
employer should be involved in the process, and that graded exposure to the work place is 
important 167,168. The RTW-I included CBT-based psychoeducation on behavioral activation, 
exposure, recovery to counteract stress, sleep strategies and problem solving. The COMBO 
condition was a combination of CBT and RTW-I.   
4.1.1.4 Statistical analyses 
Mixed-effects models were used to estimate differences between conditions in CSR and days 
on sick leave. Cohen’s d was used to estimate effect sizes for psychiatric symptoms. Chi-
squared tests were used to estimate differences between conditions in proportions of patients 
on sick leave.  
4.1.2 Results 
Main findings were that (a) CBT led to significantly larger improvements in psychiatric 
symptom severity measured by CSR than RTW-I (Cohen’s d = 0.4) at post-treatment, but no 
other differences in CSR between conditions were found, and (b) there were no differences 
between conditions in either days on sick leave or proportion of patients on sick leave.     
4.1.3 Conclusion 
CBT outperformed RTW-I in reducing psychiatric symptoms. However, when adding RTW-I 
to CBT (i.e., the COMBO condition), it was not superior to RTW-I alone, implying that the 
effects of CBT were somehow attenuated when making the intervention more extensive and 
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complex. Further, contrary to our hypothesis, the RTW-I (alone or in the COMBO condition) 
did not reduce sick leave compared to CBT. The question of how to more effectively help 
patients on sick leave due to CMDs back to a healthy work situation remains to be answered.   
4.2 STUDY II: STEPPED CARE IN PRIMARY CARE - GUIDED SELF-HELP AND 
FACE-TO-FACE COGNITIVE BEHAVIOURAL THERAPY FOR COMMON 
MENTAL DISORDERS: A RANDOMIZED CONTROLLED TRIAL 
4.2.1 Methods 
4.2.1.1 Procedure and inclusion 
Study II ran parallel to Study I. Consecutively recruited adult patients with CMDs, but not on 
sick leave, from the four primary clinics were included. Patients with sub-threshold disorder 
severity were also included (i.e., patients with symptoms within, but not fulfilling full 
diagnostic criteria for, a CMD). All patients (N = 396) received guided self-help CBT in step 
1. Patients not in remission after step 1 were randomized to continued self-help CBT or face-
to-face CBT. Patients with post-traumatic stress disorder were not included as the support for 
the efficacy of self-help treatments for this disorder was limited at the time of study start 169.  
4.2.1.2 Primary outcomes 
The primary outcome was remission status, which was operationalized as scoring below a 
predefined cut-off on a validated disorder-specific self-rated symptom scale (type of scale 
was chosen in accordance with the patient’s principal disorder). The scales were rated by 
patients at baseline, after step 1, and after step 2.  
4.2.1.3 Treatments 
In step 1, patients received a disorder-specific self-help book according to principal disorder. 
The self-help books 135,170-174 were based on evidence-based treatments, except the one for 
adjustment and exhaustion disorder that was developed by the research group (the same 
content as the face-to-face treatment described in the background of this thesis). For all 
patients, guidance consisted of two sessions with a psychologist, one at the start of treatment, 
and one approximately four weeks into treatment. In step 2, face-to-face CBT protocols were 
identical to those in Study I. For self-help CBT, the patient continued with the same book as 
in step 1, and received one additional guidance session. 
4.2.1.4 Statistical analyses 
Number of patients in remission after step 1 was reported as percentages. After step 2, the 
chi-squared test was used to estimate difference between conditions in remission status.  
4.2.2 Results 
At baseline, 333 patients (84%) rated above the pre-established cut-off on their primary 
disorder. After step 1, 134 patients (40%) of these patients were considered in remission. 
Among patients randomized in step 2 (n = 161), face-to-face CBT was significantly more 
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effective than continued self-help CBT, with 39% and 19% of patients in remission, 
respectively.  
4.2.3 Conclusion 
The investigated stepped care model yielded promising results. For patients not in remission 
after guided self-help CBT, stepping up treatment intensity to face-to-face CBT seems to be 
logic. Overall, the program resulted in high remission rates (63%), using limited therapist 
time, suggesting effective resource utilization.  
4.3 STUDY III: MEDIATORS OF CHANGE IN COGNITIVE BEHAVIOR 
THERAPY FOR CLINICAL BURNOUT 
4.3.1 Methods 
4.3.1.1 Procedure and inclusion 
This investigation of mediators of change included patients from Study I with exhaustion 
disorder as their primary disorder, randomized to CBT (n = 40) or RTW-I (n = 42).  
4.3.1.2 Primary outcomes and assessments 
Alongside the primary outcomes in Study I, patients were also assessed weekly on self-rated 
disorder-specific outcomes and potential mediators, that were used for mediational analyses. 
For exhaustion disorder, the outcome was symptoms of burnout/exhaustion (Shirom-
Melamed Burnout Questionnaire 175), and the mediators were sleep quality (Insomnia 
Severity Index 166,176), valued activation (Behavioral Activation for Depression Scale, 
Activation subscale 177), perceived competence (Perceived Competence Scale 178,179) and 
therapeutic alliance (Working Alliance Inventory 180).  
4.3.1.3 Treatments 
The treatments are described under Study I. Briefly, the CBT consisted of a protocol 
developed by the research group, with several traditional CBT components included, such as 
behavioral activation (with additional focus on recuperating activities), functional analyses, 
exposure, and optional modules (e.g., focusing disturbed sleep). The CBT was scheduled for 
9 to 13 individual sessions. The CBT is further described in the background of this thesis (see 
Table 2). The RTW-I was scheduled for 10 individual sessions and functioned as a control 
condition in this study. 
4.3.1.4 Statistical analyses 
Mixed-effects models were used to analyze change over time in outcome (the c-path) and 
mediators (the a-path). To model the effect of change in mediators on subsequent weeks’ 
change in outcome (the b-path), time-lagged mixed-effects models were used. The indirect 
effect was computed by multiplying the a-path with the b-path.  
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4.3.2 Results 
CBT led to larger effects on symptoms of exhaustion than RTW-I, and this difference in 
effects was mediated by improvements in sleep quality and perceived competence. Valued 
activation and therapeutic alliance were not found to mediate the difference in effects 
between treatments.  
4.3.3 Conclusion 
The results suggest that improved sleep and increased perceived competence may be 
important process goals related to symptom improvement in CBT for exhaustion disorder. 
4.4 STUDY IV: PROCESSES IN COGNITIVE BEHAVIOR THERAPY FOR 
SOCIAL ANXIETY DISORDER: PREDICTING SUBSEQUENT SYMPTOM 
CHANGE 
4.4.1 Methods 
4.4.1.1 Procedure and inclusion 
This process-study included patients with a primary social anxiety disorder (SAD, N = 61) 
from Study II (among the 64 patients with primary social anxiety in Study II, three did not 
fulfill full diagnostic criteria and were thus omitted from analyses). Step 1 (i.e., the guided 
self-help CBT in the first phase of the Study II) was analyzed, consequently, this study used a 
within-group design.  
4.4.1.2 Primary outcomes and assessments 
Patients were assessed weekly on outcome and the proposed change processes according to 
the cognitive model of SAD 52. The self-rated outcome was symptoms of social anxiety 
(Liebowitz Social Anxiety Scale self-report version 181,182) and the processes were estimated 
probability and cost of negative social events (Social Probability and Cost Questionnaire 
136,137), anticipatory processing, post-event processing, self-focused attention and avoidance 
(Social Phobia Weekly Summary Scale 57), and safety behaviors (Safety Behaviour 
Questionnaire, unpublished scale). 
4.4.1.3 Treatment 
The self-help book used in this trial 135 is described in the background of this thesis (see Table 
3). In brief, it consists of components typically included in CBT protocols for SAD, such as 
monitoring of negative automatic thoughts (NATs) and challenging them, behavioral 
experiments, exposure, and practice in shift of attention. The self-help book was worked 
through in nine weeks, and included two guidance sessions with a psychologist.  
4.4.1.4 Statistical analyses 
Time-lagged mixed-effects models were used to (a) estimate the effect of the presumed 
processes on subsequent weeks’ outcome, and (b) estimate the effect of the outcome on 
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subsequent weeks’ processes. This was done to analyze the temporal relations between 
changes in processes and outcome. Thus, this study focused on the b-path in a traditional 
mediational analysis. Magnitude of effects were analyzed by explained variance, pseudo-R2. 
4.4.2 Results 
Decreased avoidance predicted subsequent improvements in social anxiety, and the reversed 
direction of change (the impact reduced social anxiety on subsequent avoidance) was non-
significant. Estimated probability and cost, self-focused attention, and safety behaviors were 
bidirectionally related to social anxiety, i.e., these processes predicted subsequent social 
anxiety, but were also predicted by prior reductions in social anxiety. Effects were generally 
stronger in the presumed direction of change (compared to the reversed direction). 
Anticipatory and post-event processing did not predict subsequent social anxiety, but were 
predicted by prior symptom reduction. 
4.4.3 Conclusion 
The results indicate that several of the proposed change processes according to the cognitive 
model of SAD (except for worry and post-mortem rumination) are related to subsequent 
improvements in social anxiety. However, only avoidance showed a unidirectional relation to 
subsequent social anxiety, which suggests that this process might be of specific clinical 
relevance. The remaining processes seem to be part of reciprocal positive cycles, that is, 
improvements in processes and symptoms affect each other.  
4.5 STUDY V: INFLAMMATORY CYTOKINES IN PATIENTS WITH COMMON 
MENTAL DISORDERS TREATED WITH COGNITIVE BEHAVIORAL 
THERAPY 
4.5.1 Methods 
4.5.1.1 Procedure and inclusion 
This study of inflammatory correlates of change included patients (N = 367) from Study I and 
II. Patients included in either of these clinical trials were asked for participation. The study 
used a within-group design.  
4.5.1.2 Primary outcomes and assessments 
Self-rated psychiatric symptoms and inflammatory markers were assessed at pre- and post-
treatment. Symptom domains were depression (Montgomery Åsberg Depression Rating Scale 
Self-rated 183), stress (Perceived Stress Scale 184), and anxiety (Hospital Anxiety and 
Depression Scale, Anxiety subscale 185). Inflammatory markers analyzed were pro-
inflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6) and IL-8. 
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4.5.1.3 Treatments 
Treatments are described under Study I and Study II. In sum, they consisted of one of the 
following conditions: CBT, RTW-I, COMBO, guided self-help CBT, guided self-help CBT + 
continued guided self-help CBT, or guided self-help CBT + face-to-face CBT.  
4.5.1.4 Statistical analyses 
Baseline correlations between psychiatric symptom severity and level of pro-inflammatory 
cytokines were analyzed using linear regression. Changes in symptoms and cytokines over 
time (pre-to-post) were analyzed using mixed-effects models. Both these analyses included 
potential moderators and confounders. Finally, Spearman rank correlation was used to 
analyze the association between changes in symptoms and changes in cytokines.  
4.5.2 Results 
At baseline, levels of symptoms and cytokines were significantly associated in subgroups 
(e.g., levels of TNF-α were related to levels of all symptom measures in men, but not in 
women), but no robust associations across the study sample were found. Symptom severity 
decreased markedly between pre- and post-treatment, but cytokine levels were unchanged. 
There was no association between changes in symptoms and changes in cytokines.  
4.5.3 Conclusion 
Pro-inflammatory cytokines were related to psychiatric symptom severity only in subgroups. 
Although symptoms were substantially reduced after treatment, cytokine levels did not track 
this improvement, suggesting a limited role of these inflammatory processes in CBT for 
CMDs.  
4.6 ETHICAL CONSIDERATIONS 
All studies were approved by the regional ethics committee in Stockholm, Sweden. First, the 
clinical trials (Study I and II, including analyses for Study III and IV in the present thesis) 
were approved. Subsequently, by an amendment to the approved application, the study of 
inflammatory markers (Study V) was granted. All patients provided written informed consent 
and were free to terminate study participation at any time. An additional informed consent 
was provided for Study V. If participation in either clinical trial was declined, patients were 
offered treatment according to the clinics’ routine care. All parts of the studies were 
conducted in line with the Declaration of Helsinki Ethical Principles 186. The trials were 
preregistered at ClinicalTrials.gov (identifiers NCT01636791 and NCT01667822). 
In Study I, one of the conditions to which patients were randomized was the RTW-I. This 
constitutes an ethical consideration because RTW-I is not an evidence-based treatment. 
However, only a minority of patients with CMDs that present in primary care (and specialist 
care) in Stockholm receive evidence-based treatments. The structured format of the RTW-I 
condition, as well as the CBT-based psychoeducation, makes this a tolerable treatment in this 
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regard. In retrospect, effects on symptoms were substantial in RTW-I (although larger in 
CBT).  
In Study II, non-responders to guided self-help CBT were randomized to face-to-face CBT or 
continued guided self-help CBT. The latter condition served as a control condition to 
examine the potential additive effects of stepping up treatment intensity. Thus, some patients 
received treatment where therapeutic effects were expected to be limited. However, the 
potentially additive effects of face-to-face CBT in this second step of treatment were 
uncertain before the study, and the potential benefits of this research were seen as large.  
Regarding the self-rated measures of mediators/processes and outcome, patients spent 
approximately 20 minutes weekly to rate 60-75 items (depending on primary disorder). This 
constituted an extra burden for some patients already suffering from stress-related problems. 
However, the experience of treating some of these patients was that most of them found the 
weekly measures not too demanding, but rather appreciated the carefulness given to 
monitoring changes in symptoms and processes over time. Generally, ratings were used 
jointly to monitor progress, that is, both patient and psychologist benefitted from the weekly 
provided information.  
After patients had accepted participation in the either clinical trial (Study I or II) they were 
asked about additional participation in the study of inflammatory markers (Study V). 
Participation was voluntary and did not affect participation in the clinical trials. Thus, patients 
were free to participate in the treatment studies without contributing with blood samples 
before and after treatment. If participation was accepted, blood samples were collected by 
trained personnel at certified laboratories at the respective primary care clinic. The risk of 
nerve damage associated with venipuncture was assessed as very limited.  
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5 DISCUSSION 
The aim of this thesis was to investigate processes of change in CBT for CMDs. Specifically, 
focus was placed on psychological change processes in CBT for exhaustion disorder (ED) 
and social anxiety disorder (SAD), and inflammatory processes in a broad sample of patients 
with CMDs. These process studies were based on two large clinical trials of CBT for CMDs 
set in primary care.  
5.1 MAIN FINDINGS  
In Study I and II, the clinical trials, CBT was found to produce favorable effects on 
psychiatric symptoms. In Study I, CBT was superior to a strong comparison condition (RTW-
I). In Study II, a stepped care model resulted in high overall remission rates. Thus, the clinical 
trials constituted a beneficial base for further investigation of processes involved in 
therapeutic improvement. In Study III, patients with a primary ED from Study I were 
investigated regarding mediators of change. Sleep quality and perceived competence were 
found to mediate the favorable effects of CBT compared to RTW-I, while behavioral 
activation and therapeutic alliance were not significant mediators. In Study IV, processes of 
change were investigated in patients from Study II with a principal diagnosis of SAD who 
received guided self-help CBT. Reductions in the following processes were found to predict 
subsequent reduction in social anxiety: estimated probability and cost of negative social 
events, self-focused attention, avoidance, and safety behaviors. Notably, all these processes, 
except avoidance, were also found predicted by prior symptom reduction. Only worry and 
post-mortem rumination were not found predictive of subsequent social anxiety. In Study V, 
patients from both Study I and II were analyzed regarding inflammatory markers related to 
psychiatric symptoms. Results showed that inflammation and symptoms were only associated 
in subgroups at baseline, and the large symptom improvements over the treatment period 
were not correlated to reductions in inflammation. In the following, results of the clinical 
trials (Study I and II) will be discussed briefly, followed by a more extensive discussion of 
the process studies (Study III-V). 
5.2 EFFECTIVENESS OF CBT FOR COMMON MENTAL DISORDERS IN 
PRIMARY CARE 
The results of Study I support that disorder-specific face-to-face CBT is a suitable treatment 
option for CMDs in primary care, as showed by superior effects on psychiatric symptoms 
compared to another comprehensive psychological treatment (i.e., RTW-I). These results are 
in line with a large body of evidence supporting that CBT is efficacious for a wide range of 
disorders 187, for a review of meta-analyses, and also that CBT is effective in the primary care context 
113,188. In contrast to our hypothesis, the results of Study I do not support that an intervention 
that primarily focuses on work issues (RTW-I) has beneficial effects on sick leave, as 
compared to disorder-specific CBT. Recent systematic reviews and meta-analyses 
investigating the effect of interventions on sick leave in CMDs have produced inconsistent 
results and effects seem to be small 100,110,189,190. The combined intervention (COMBO) in 
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Study I was not superior to any of the other treatments, either on symptoms or sick leave. In 
speculation, the COMBO treatment was too extensive for both therapists and patients.  
In Study II, results support that a stepped care model could be a viable solution to increase 
access to evidence-based treatments for patients with CMDs in primary care. Some recent 
studies have shown promising results of stepped care models for obsessive-compulsive 
disorder 105; panic disorder and social anxiety disorder 106; panic disorder and generalized 
anxiety disorder 108; and anxiety disorders, adjustment disorder and depression 109. The results 
of Study II add to existing knowledge, particularly by showing that non-responders to guided 
self-help CBT can benefit from being stepped up to face-to-face CBT. This way, high 
remission rates can be achieved with limited therapist resources.   
5.3 WHAT CAN WE LEARN FROM INVESTIGATING MEDIATORS OF CHANGE 
IN CBT FOR EXHAUSTION DISORDER? 
As of today, no evidence-based treatments exist for exhaustion disorder (ED). CBT seems 
effective for work-related stress 99, but results for clinical populations are more uncertain 100-
103. Moreover, process studies of CBT for ED are lacking. A vital step in developing effective 
treatment for this patient group is to investigate mediators of change in the context of clinical 
trials.  
An important finding in Study III was that sleep quality mediated the effect on symptoms of 
exhaustion: sleep improved more in CBT than RTW-I (a-path), sleep improvements predicted 
subsequent reductions in exhaustion (b-path), and the mediated effect (a*b product) was 
significant. Thus, sleep seems to be an interesting construct for further investigation in CBT 
for ED. If replicated, it implicates that sleep disturbance should be targeted in treatment. 
Clearly, one way to modify the present CBT protocol is to include evidence-based sleep 
strategies (e.g., sleep restriction and stimulus control 94) earlier in treatment. Further, if future 
research finds moderated mediation (i.e., that higher levels of sleep disturbance at baseline is 
associated with a stronger mediated effect on exhaustion through sleep improvements), sleep 
strategies should be especially emphasized for patients with higher levels of insomnia at 
treatment start.   
What do these results tell us about the actual mechanisms of change? Although sleep quality 
can be viewed as a mediator (a variable that statistically explains the relationship between an 
independent and a dependent variable 114), it does not give information of the steps and 
processes connecting the investigated CBT protocol, sleep improvements and reduced 
exhaustion. Increase in recuperating behaviors and reduction in perseverative cognitions 
could be intermediate steps involved in fostering improved sleep in the context of stress 43,45. 
Longitudinal investigation of the interrelations between these processes and their effect on 
exhaustion in future treatment trials is warranted.  
Further, it should be noted that sleep quality in Study III was operationalized by the Insomnia 
Severity Index 166,176. Although this scale includes items concerning sleep disturbance (i.e., 
difficulties falling asleep, maintaining sleep and early awakening), it also includes items 
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regarding consequences of disturbed sleep (e.g., worry about the sleeping pattern). Some 
important aspects of sleep quality are however not included (e.g., sleep duration and sleep 
efficiency). Other scales (such as the Pittsburgh Sleep Quality Index 191), as well as sleep 
diary data and objective sleep assessment, could contribute with more detailed information of 
the role of sleep in improvements from exhaustion. 
The other significant mediator in Study III was perceived competence, a concept close in 
meaning to self-efficacy 192. In this context, the construct refers to an individual’s belief in the 
ability to cope with ED. Thus, some of the superior effects of CBT compared to RTW-I on 
symptoms of exhaustion were mediated by increased confidence in coping abilities. Further 
elucidation of these relations is, of course, of interest. For example, what components of the 
investigated CBT protocol (e.g., psychoeducation about stress, self-observation, functional 
analysis of emotion-provoking situations, planning recuperating activities etc.) lead to 
increased perceived competence (e.g., “I feel confident in my ability to manage my 
exhaustion disorder”)? And what additional processes (e.g., cognitive and behavioral) are 
involved in the subsequent effect on exhaustion? Relatedly, how does perceived competence 
interplay with behavioral changes to promote changes in well-being? Recovery-related self-
efficacy 193 might, for example, increase the probability of engaging in recuperating activities.  
Although the present CBT protocol leans heavily on behavioral activation, valued activation 
was not found a significant mediator in Study III. In this context, it should be noted that we 
analyzed the presumed mediators in relation to the difference in effects between treatments. 
Thus, behavioral activation could be a mediator in both treatments, if analyzed separately. 
Indeed, the b-path in the present analysis was significant (i.e., increased behavioral activation 
predicted subsequent symptom level across treatments). Further, although the a-path was 
non-significant (i.e., no difference in effects in valued activation between treatments), they 
both produced substantial within-group changes in valued activation (estimated Cohen’s d = 
1.23 and 1.28 at post-treatment, respectively, found in supplement Table S5 in the article). 
One interpretation of this finding is that psychoeducation, as well work-related strategies, in 
the RTW-I resulted in marked behavioral activation, comparable to the one found in CBT. 
Behavioral activation could therefore be further examined as a possible mediator of change in 
CBT against a comparator that does not involve similar treatment components. 
Of note, we did not measure recovery explicit in Study III, which is unfortunate. By the start 
of the present studies, I was not aware of valid measures of recovery. Valued activation, as 
measured by the Behavioral Activation for Depression Scale, Activation subscale (that 
includes variety and structure in daily activity) was used in part as a proxy. However, explicit 
measure of recovery would have been preferably. Some recent recovery-focused programs 
for stress have examined both recovery activities (e.g., physical activities) and recovery 
experiences (e.g., psychological detachment from work) 194 with promising results 35,43,193. 
One suitable measure is the Recovery Experience Questionnaire 195, covering different facets 
of recovery (e.g., both psychological detachment and relaxation). Noteworthy, previous 
research has mainly focused on (a) occupational stress and not clinical populations, and (b) 
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recovery in relation to work. Consequently, investigation of the mediating role of recovery in 
CBT for ED is still needed.   
Therapeutic alliance was not found a significant mediator in Study III. However, null-
findings concerning alliance as a mediator does not, of course, mean that it lacks importance 
in treatment. Rather, several other perspectives on therapeutic alliance (not investigated in the 
present study) are possible. For instance, initial level of alliance could be a predictor of 
treatment outcome or alliance could facilitate changes induced by specific treatment 
ingredients 114,196. Also, as argued regarding behavioral activation, it should be noted that the 
potential role of therapeutic alliance as a mediator of change was analyzed in relation to the 
difference in effects between treatments. However, the b-path (the effect of therapeutic 
alliance on subsequent symptoms of exhaustion across treatments) was non-significant (see 
Table 2 in the article), which limits motivation for further investigation.  
5.4 HOW DOES CHANGE UNFOLD IN SOCIAL ANXIETY DISORDER? 
In contrast to the evidence base of CBT for exhaustion disorder, there is strong support for 
the effectiveness of CBT for social anxiety disorder (SAD), in both face-to-face treatment 
and guided self-help 88. Nevertheless, not all patients benefit from treatment. About 25% of 
patients do not achieve clinically significant improvement even following the most 
efficacious face-to-face protocol (cognitive therapy) 197. Further, the theoretical basis for 
treatment concerning the maintaining processes has been studied widely 53. However, one 
limitation in previous research is the timeline of events in CBT for SAD. Do the presumed 
processes really precede change in outcome?  
In Study IV, several of the investigated processes (i.e., estimated probability and cost of 
negative social events, self-focused attention, and safety behaviors) were found to have 
reciprocal relations with social anxiety, which has also been found in previous studies using 
repeated measures of processes and outcome 145,147-149. Thus, we were not able to provide 
insight into the order of change between these proposed processes and outcome, although 
effects pointed to more variance being explained by processes on subsequent symptoms, than 
the reversed relation. One interpretation of these bidirectional relations is that reductions in a 
process affects social anxiety, which in turn has beneficial effects on the process. Conversely, 
the results could also mean that a third, unmeasured, variable caused effects in both processes 
and social anxiety. In that case, important treatment targets are yet to be discovered.    
Avoidance unidirectionally predicted subsequent social anxiety, while worry and post-
mortem rumination were unidirectionally predicted by prior reduction in social anxiety. 
These results could implicate that to achieve reductions in social anxiety, it is important to 
target avoidance in treatment, while worry and post-mortem rumination should not hold such 
position in treatment. Importantly, Study IV was not randomized. Consequently, changes in 
processes could have been caused by other factors than treatment. In other words, avoidance 
seems to be important for symptom reduction, but the cause of decreased avoidance in Study 
IV was not necessarily the guided self-help CBT.  
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Further, given the number of presumed change processes in CBT for SAD, an interesting line 
of future research is the interplay between key processes. A recent review proposed an 
extended model of maintenance of SAD that take etiological factors, as well as the sequential 
development of different maintaining processes, into account 53. In such a model, primary 
maintaining processes (i.e., attentional biases directed toward detection of threat and 
avoidance/escape behaviors that are intended to eliminate threat) are viewed as predictive of 
later development of secondary maintaining processes (i.e., anticipatory- and post-event 
processing and safety behaviors). For example, avoidance as an initial strategy to eliminate 
exposure to social threat/evaluation is proposed to lead to later development of more subtle 
strategies, i.e., safety behaviors, serving the same function. Correspondingly, process change 
in CBT for SAD might unfold sequentially, so that relieve in one process affects another, that 
eventually has impact on symptoms. In Study IV, each process was investigated in isolation 
in relation to the outcome. Single-case designs might offer advantages in this regard, 
including isolating active components in treatment packages 198. Ultimately, ordering of 
treatment components may be optimized. For example, self-focused attention is targeted in 
chapter 6 in the present self-help book 135, while earlier implementation might be beneficial 
for outcome. 
A central part of the cognitive model of SAD is the ‘processing of self as social object’, 
including self-focused attention and images/impressions of how one appears to others 52. In 
Study IV, self-focused attention was measured, as in previous studies 145-147. However, 
assessment of the occurrence of negative self-images would have added important 
information. Relatedly, self-images might be influenced by memories of socially traumatic 
events 59,60, and treatment development would benefit from more knowledge about this 
potential process. 
An important limitation of Study IV is the within-group design. Nevertheless, an important 
gap in existing knowledge is the investigated temporal relations between processes and 
outcome (the b-path in a traditional mediational analysis), while the a-path (i.e., the effect of 
treatment on mediators) and the c-path (i.e., the effect of treatment on outcome) have 
received more attention in previous research.  
5.5 WHAT IS THE ROLE OF INFLAMMATION IN COMMON MENTAL 
DISORDERS? 
In Study V, measures of inflammation were not associated with psychiatric symptom severity 
across the study sample; significant associations between inflammatory cytokines and 
symptom severity were only found in subgroups. Further, inflammatory markers were not 
reduced after CBT, and the substantial symptom improvements were not correlated to 
cytokine reductions.  
One caveat concerning our results of the baseline associations is that inflammation might not 
be relevant to psychiatric symptoms in all patients. For example, there might be a depressive 
subtype where elevated inflammation is involved (i.e., for some individuals’ immune 
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processes might be particularly relevant for depression development), whereas for other 
depressed individuals it is not 199. This notion might apply across CMDs. Further, how should 
our null-findings concerning change over time in cytokines be interpreted? One way is to 
infer a true absence of effects of CBT on inflammatory markers in the studied population. 
Given the large sample size (largest to date), the gold-standard method of cytokine 
assessment (manual enzyme-linked immunosorbent assays) 200, and the structured and 
protocol-based treatments used, it might be argued that undetected true changes are 
improbable. On the other hand, there are aspects of Study V that could have masked effects. 
Some important confounders were not measured (e.g., use of medication during treatment), 
blood samples were not drawn at specific times (i.e., permitting circadian variations in 
inflammatory levels 201 to possibly influence the results), and there was a mix of CBT 
treatments (e.g., the RTW-I included CBT psychoeducation, but did not aim primarily at 
symptom reduction). These factors hinder firm conclusions from the study. Moreover, 
analyses of change over time in cytokines might be relevant only for patients with elevated 
inflammatory markers at baseline (which could be a proxy for the inflammatory-related 
subtype of patients). In Study V, the within-group design and associated issue of regression to 
the mean unfortunately precluded such analyses.  
There are also points to be made concerning assessments of inflammatory markers in Study 
V. Blood samples were drawn twice, at pre- and post-treatment, as in the vast majority of 
previous studies 160. This carries some limitation. First, low-grade chronic inflammation is 
assumed to contribute to CMDs. Consequently, multiple baseline assessment of inflammatory 
markers would have been informative. Second, and maybe more important for the process 
focus of the present thesis, we did not measure cytokines repeatedly during treatment. To 
investigate the possibility of a mediating role of reduced inflammation on subsequent 
outcomes, frequent assessments are vital. One of few studies using repeated measures of 
inflammatory markers investigated the effects of a CBT stress management program for 
coronary heart disease patients 202, and inflammatory markers were assessed at five 
timepoints. However, although a solid design, the biomarkers were not reduced over time, 
and mediational analyses were therefore not conducted. Further, although markers of 
inflammation in peripheral blood can serve as proxies for central inflammation 203, we did not 
measure immune processes relevant for CMDs in the brain.  
Moreover, there are alternatives to the suggested role of inflammation in relation to CBT in 
the Study V. This study hypothesized that CBT could have anti-inflammatory effects. 
However, inflammation can also be viewed as a moderator of treatment effect. A recent meta-
analysis suggests that baseline inflammation might predict non-response to anti-depressant 
pharmacological treatment for depression 204. This moderating role of inflammation might 
also be true for psychological treatments. The cytokine-induced sickness response has been 
described as a motivational state 63. In learning theory terms, this could be translated to 
“establishing operations”, that is, circumstances that influence the strength of reinforcers and 
thus operant behaviors. Just as thirst can increase behaviors directed towards acquiring 
something to drink, the sickness response could decrease the tendency to try new behaviors 
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inherent in CBT (such as exposure or valued activation). Elevated inflammation could in this 
sense obstruct treatment outcome, which has been indicated in some studies 205-207. This is an 
interesting line of research that could help in decisions regarding for which patient anti-
inflammatory pharmacological treatment might be considered as an adjunct to behavioral 
treatment. 
Given the uncertainty in current research, inflammation in relation to CBT could be posited 
as a correlate of change (e.g., a physiological observational level of symptom change), a 
consequence of symptomatic change (e.g., emotional improvements leading to reduced 
inflammation), a potential process of change (i.e., preceding symptom reduction), a 
moderator of treatment effect (i.e., predicting response to treatment), or largely unrelated to 
treatment effect. Moreover, if CBT has anti-inflammatory effects, how does such changes 
unfold? Decreased HPA-axis and sympathetic activity could be one pathway 151, but 
improvements in important health-promoting behaviors associated with inflammatory 
processes (e.g., regarding physical activity, diet and smoking) 67,208 are also possible routes. 
Of note in this respect, CBT for CMDs generally does not directly target such behaviors.  
In sum, inflammation was not related to improvements in this heterogenous sample of 
patients with CMDs. The results suggest that if CBT has anti-inflammatory effects 209, they 
are likely of limited importance for clinical improvement.  
5.6 CLINICAL IMPLICATIONS 
The clinical studies showed that implementing structured and protocol-based CBT in primary 
care yields substantial treatment effects and that a stepped care model could be a viable 
solution to increase access to evidence-based treatments. Further, although tentative, the 
results of the present process studies might have some implications for treatment 
improvements. First, targeting disturbed sleep could be important for symptom improvement 
in CBT for exhaustion disorder. Early and structured implementation of sleep enhancing 
strategies might hold promise. Second, the maintaining processes according to the cognitive 
model of social anxiety disorder 52 were largely supported, and, speculatively, targeting 
avoidance might be of particular relevance to reduce social anxiety. Further, worry and post-
mortem rumination might only be consequences of symptom improvement, and may 
therefore be of less clinical importance. Concerning inflammation, the present results mainly 
have implications for future research.  
5.7 GENERAL METHODOLOGICAL ISSUES AND FUTURE DIRECTIONS 
Studies of processes of change in clinical trials has the potential to ultimately produce better 
patient outcomes. However, there are several issues regarding these kinds of investigations 
that should be mentioned.  
Bringing clarity to mechanisms of change in CBT for a particular disorder is a vast project, 
and the results of one study can only contribute with limited answers 114. For example, the 
present finding concerning the role of sleep improvements in ED is, although interesting, 
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merely a starting point for future research. What CBT components, given the broad treatment 
package, lead to sleep improvement? Are there redundant components that could be omitted 
from the protocol? What intermediate process were involved? Relatedly, the b-path in 
mediational analyses (i.e., the effect of the mediator on outcome) is correlational by nature. 
The experimental manipulation (i.e., treatment allocation) controls for confounders in the c-
path (i.e., the effect of treatment on outcome) and a-path (i.e., the effect of treatment on 
mediator), but not in the b-path. To claim that changes in the mediator causes changes in the 
outcome, the mediator needs to be manipulated (i.e., randomizing patients to different levels 
of the putative mediator, which is difficult in many cases) 210. Thus, to say that sleep 
improvements cause improvements in symptoms of exhaustion, one would essentially need to 
allocate patients with ED to different levels of sleep quality and analyze the effects on 
exhaustion.  
Concerning investigation of the timeline (i.e., whether changes in processes precede changes 
in outcome), it is widely acknowledged that both processes and outcome should to be 
measured repeatedly during treatment. However, although a progress from previous pre-to-
post analyses, weekly assessments might not be enough. As seen in Study IV, reciprocal 
relations between most of the investigated processes and outcome indicate that improved 
resolution is warranted. Theoretically, one could assume that some therapeutic changes (e.g., 
cognitive changes after a successful behavioral experiment) are almost instant. Tracking such 
changes in relation to changes in outcome (e.g., social anxiety) on tighter than weekly 
schedules would be informative. Conversely, changes could also unfold over longer time 
periods, and examination of process-outcome relations could benefit from analyses with 
different time-lags.    
Further, although the time-lagged mixed-effects analyses (i.e., investigating the subsequent 
effect of one variable on another, in the present studies with a one week time-lag) used in 
Study III and IV have many advantages, there are also limitations. One is that effect sizes are 
not easily calculated or interpreted. Few would today find it sufficient to know that the 
difference in outcome between two treatments was statistically significant – the clinical 
significance/magnitude of difference is vital information. Likewise, a mediator may be 
related to outcome, but knowing the effect size of the relation has important implications. In 
Study IV, we calculated explained variance as a measure of the magnitude of effect. 
However, as evident in that paper, some of these calculations yielded uninterpretable results 
as to the size of effects.      
Another issue concerning statistical analyses is that relations between processes and outcome 
need to capture what unfolds within individuals 211. Therapeutically, the focus is to attain 
changes in processes believed to help the specific patients on some valued outcome. In 
research, analyses of process-outcome relations on a group level can confuse relations that 
occur between individuals (e.g., individuals with higher self-focused attention have more 
severe social anxiety) and within individuals (e.g., an individual that reduces self-focused 
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attention subsequently improve on social anxiety). In Study IV we explicitly modeled change 
over time with regard to this issue, which has been a limitation in previous research 145.  
On a broader note, knowledge on mediators of change is important for treatment 
development. Moreover, understanding of potential mechanism can help to discover 
moderators of treatment outcome (i.e., characteristics that affect the relation between an 
intervention and outcome), which concerns matching patients with treatment to improve 
benefit 20,117. For example, attention training in SAD may only be an effective treatment 
component for patients with tangible attentional biases at treatment start 212. As of today, 
treatment packages are often implemented on basis of the patient’s primary disorder. Process-
informed decisions of treatment, or treatment components, may be an important way to 
increase the effectiveness of psychological treatments and alleviate suffering in the many 
persons affected by CMDs.  
5.8 CONCLUSIONS 
Implementing structured and protocol-based CBT for CMDs in primary can yield substantial 
treatment effects and stepped care CBT could be a way to increase accessibility. However, 
there is considerable room for improvement in outcomes and the present process studies 
gives some clues, although tentatively, to treatment development. Targeting disturbed sleep 
seems to be important in CBT for exhaustion disorder. Also, improving perceived 
competence, the belief in one’s ability to cope, seems to be of value. In social anxiety 
disorder, reducing avoidance might be of particular relevance to attain symptom reduction, 
although several other processes seem to be involved. As to immune system dysregulation, 
inflammatory processes seem to play a limited role in CBT for CMDs.
  41 
6 ACKNOWLEDGEMENTS 
Erik Hedman, my main supervisor. I am so extremely grateful for all your excellent support. 
You convinced me to do this, by a well-targeted pitch in June 2012. Then you guided me 
through years of distress in such a warmhearted and intelligent manner. You have constantly 
been by my side, providing whatever support I needed, whenever I needed it. Thank you for 
being so smart, steady, knowledgeable, present, available, patient and fun. You have been a 
perfect supervisor, in every aspect of it.  
Mats Lekander, my co-supervisor. You have introduced me to a new field, and done it from 
such a humble and curious standpoint. Thank you for showing me how to stay open and 
honest, also after decades of research. And thank you for your perfect timing in giving me 
support and encouragement. Brjánn Ljótsson, my co-supervisor. Thank you for all I had the 
privilege to learn from you on writing, analyzing, thinking, and re-thinking. And thank you 
for making me feel that help was always close. Göran Kecklund, my co-supervisor. The 
papers on sleep disappeared on the way, but I learnt a lot from you on the way. Thank you for 
your positive energy, and for all feedback and encouragement on manuscripts.   
Sigrid Salomonsson, my friend and former fellow PhD student and boss. You carried me on 
your back for almost ten years, was it never heavy? Thank you for letting me follow you. 
And thank you for excellent cooperation, we struggled hard but we made it. Elin Lindsäter, 
my friend, colleague and fellow PhD student. You are so dedicated to everything you do, and 
you do things with such passion and energy. I truly appreciate working with you, it is a great 
mix of learning, productivity and laughter. 
Anna Andreasson, working with you has been a true pleasure (excluding those freezing days 
in the KI cellar). Thank you for all support, guidance and knowledge. Hugo Hesser, I am 
thankful for your enormous patience when helping me with statistical analyses. You gave me 
time and encouragement to actually understand some of it. Lars-Göran Öst, you are tough, 
fair and extremely helpful. Thank you for your persistent pursuit of getting things right. 
Daniel Hultell, my mentor and friend. Without your mentoring, this would still have worked. 
Nevertheless, I knew I had your support.   
Patients taking part in the trials, thank you for participating and for completing all self-report 
measures, even though many of you already had excessive stress in your lives. Psychologists 
conducting therapy in the trials, thank you for your excellent work.     
Kalle Simonsson, my friend and colleague, and nowadays also boss. You see things so 
clearly; you never lose track of the big picture and you always aim for what is really 
important. It is truly inspiring to be around such superpowers. Kersti Ejeby, head of 
Gustavsberg’s primary care clinic, your dedication to improve treatment in primary care was 
essential for this project, as well as for the high quality of our clinic today. Colleagues at 
Gustavsberg’s primary care clinic, thank you for contributing to a workplace I am proud of. 
Karoline Kolaas and Johan Lundin, I learned so much from working with you, thank you.   
  42 
Fredrik Folke, my earlier supervisor, your theoretic passion and admirable therapeutic skills 
made me choose CBT back in 2008. Klara Sternbrink, how lucky I was to have you as my 
first supervisor and boss when I started working as a psychologist. I don’t think I could have 
had a better start.  
Johan, dear brother, you pulled of the greatest stunt of all, making me believe I was a 
researcher. Your strategy was so simple, yet so genius. And that is just the tip of the iceberg 
of your importance. Gabbe, aside our friendship, thank you for all our discussions on 
research, from ethics and statistics to the option of just resigning. You have helped keep me 
on track. Simon, my constant support, you are wiser than most wise people. Thank you for 
seeing things I don’t, and telling me about them. Anders, dear little brother, your intelligence 
has inspired me since you were very young. Although I will never be as smart as you, I will 
never be as physically strong either. Mom, dad and Britt, thank you for giving me a solid base 
that enabled me to believe I could do this, thank you for everything you still do for me.  
Johanna, Charlie and Love, my amazing family. Johanna, you still fascinate me. Thank you 
for being you, for our team, for our family, for our warm and loving home, and for your 
enormous support in everything. Charlie and Love, my adorable boys, you make life feel 
extremely rich and fortunate. I love you more than I thought possible.  
    
 
  43 
7 REFERENCES 
 
1. Carter KC. Ignaz Semmelweis, Carl Mayrhofer, and the rise of germ theory. Med Hist 
1985; 29(1): 33-53. 
2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, 
and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey 
Replication. Arch Gen Psychiatry 2005; 62(6): 617-27. 
3. Casey P. Adjustment disorder: new developments. Curr Psychiatry Rep 2014; 16(6): 
451. 
4. Morin CM, Benca R. Chronic insomnia. The Lancet 2012; 379(9821): 1129-41. 
5. Glise K, Hadzibajramovic E, Jonsdottir IH, Ahlborg G, Jr. Self-reported exhaustion: a 
possible indicator of reduced work ability and increased risk of sickness absence 
among human service workers. Int Arch Occup Environ Health 2010; 83(5): 511-20. 
6. Wiegner L, Hange D, Bjorkelund C, Ahlborg G, Jr. Prevalence of perceived stress 
and associations to symptoms of exhaustion, depression and anxiety in a working age 
population seeking primary care--an observational study. BMC Fam Pract 2015; 16: 
38. 
7. Ormel J, Petukhova M, Chatterji S, et al. Disability and treatment of specific mental 
and physical disorders across the world. Br J Psychiatry 2008; 192(5): 368-75. 
8. Saarni SI, Suvisaari J, Sintonen H, et al. Impact of psychiatric disorders on health-
related quality of life: general population survey. Br J Psychiatry 2007; 190: 326-32. 
9. Henderson M, Harvey S, Overland S, Mykletun A, Hotopf M. Work and common 
psychiatric disorders. Jrsm 2011; 104(5): 198-207. 
10. National Institute for Health and Clinical Excellence [Nice]. Common mental health 
problems: identification and pathways to care. 2011. Available at 
https://www.nice.org.uk/guidance/cg123 (accessed February 6, 2019). 
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental 
Disorders. 5th ed. Washington, DC; 2013. 
12. The Swedish National Board of Health and Welfare. Utmattningssyndrom. 
Stressrelaterad psykisk ohälsa. [Exhaustion Syndrome. Stress related mental illness]. 
(in Swedish). Stockholm: National Board of Health and Welfare; 2003. 
13. Beser A, Sorjonen K, Wahlberg K, Peterson U, Nygren A, Asberg M. Construction 
and evaluation of a self rating scale for stress-induced exhaustion disorder, the 
Karolinska Exhaustion Disorder Scale. Scand J Psychol 2014; 55(1): 72-82. 
14. Grossi G, Perski A, Osika W, Savic I. Stress-related exhaustion disorder--clinical 
manifestation of burnout? A review of assessment methods, sleep impairments, 
cognitive disturbances, and neuro-biological and physiological changes in clinical 
burnout. Scand J Psychol 2015; 56(6): 626-36. 
15. Hasselberg K, Jonsdottir IH, Ellbin S, Skagert K. Self-reported stressors among 
patients with exhaustion disorder: an exploratory study of patient records. BMC 
Psychiatry 2014; 14: 66. 
  44 
16. The Swedish Social Insurance Agency. Sjukskrivningsmönster [Social Insurance 
Report 2017:3]. (in Swedish), 2017. 
17. Heimberg RG, Hofmann SG, Liebowitz MR, et al. Social anxiety disorder in DSM-5. 
Depress Anxiety 2014; 31(6): 472-9. 
18. Crome E, Grove R, Baillie AJ, Sunderland M, Teesson M, Slade T. DSM-IV and 
DSM-5 social anxiety disorder in the Australian community. Aust N Z J Psychiatry 
2015; 49(3): 227-35. 
19. American Psychiatric Association. Diagnostic and statistical manual of mental 
disorders : DSM-IV-TR. 4th ed. Washington, DC; 2000. 
20. Holmes EA, Ghaderi A, Harmer CJ, et al. The Lancet Psychiatry Commission on 
psychological treatments research in tomorrow's science. The Lancet Psychiatry 
2018; 5(3): 237-86. 
21. Dixon MR, Rehfeldt RA. Core behavioral processes. In: Hayes SC, Hofmann SG, 
eds. Process-based CBT: the science and core clinical competencies of cognitive 
behavioral therapy. Oakland: New Harbinger Publications; 2018. 
22. Skinner BF. About behaviorism. New York: Random House; 1976. 
23. Houwer JD, Barnes-Holmes D, Barnes-Holmes Y. What is cognition? A functional-
cognitive perspective. In: Hayes SC, Hofmann SG, eds. Process-based CBT: the 
science and core clinical competencies of cognitive behavioral therapy. Oakland: 
New Harbinger Publications; 2018. 
24. Törneke N. Relationsinramningsteori - RFT : teori och klinisk tillämpning. Lund: 
Studentlitteratur; 2014. 
25. Beck AT. Cognitive Therapy: Nature and Relation to Behavior Therapy. Behav Ther 
1970; 1: 184–200. 
26. Clark DA, Beck AT. Cognitive theory and therapy of anxiety and depression: 
convergence with neurobiological findings. Trends Cogn Sci 2010; 14(9): 418-24. 
27. Powers MB, de Kleine RA, Smits JAJ. Core Mechanisms of Cognitive Behavioral 
Therapy for Anxiety and Depression: A Review. Psychiatr Clin North Am 2017; 
40(4): 611-23. 
28. Eizenman M, Yu LH, Grupp L, et al. A naturalistic visual scanning approach to assess 
selective attention in major depressive disorder. Psychiatry Res 2003; 118(2): 117-28. 
29. Lichtenstein-Vidne L, Okon-Singer H, Cohen N, et al. Attentional bias in clinical 
depression and anxiety: The impact of emotional and non-emotional distracting 
information. Biol Psychol 2017; 122: 4-12. 
30. Salkovskis PM. The importance of behaviour in the maintenance of anxiety and 
panic: A cognitive account. Behavioural Psychotherapy 1991; 19(1): 6-19. 
31. Salkovskis PM, Hackmann A, Wells A, Gelder MG, Clark DM. Belief 
disconfirmation versus habituation approaches to situational exposure in panic 
disorder with agoraphobia: a pilot study. Behav Res Ther 2006; 45(5): 877-85. 
32. Clark DM. Anxiety disorders: Why they persist and how to treat them. Behav Res 
Ther 1999; 37(Suppl 1): S5-S27. 
  45 
33. American Psychological Association. What is Cognitive Behavioral Therapy? 
Clinical practice guideline for the treatment of posttraumatic stress disorder. 2017. 
Available at https://www.apa.org/ptsd-guideline/patients-and-families/cognitive-
behavioral.aspx (accessed December 20, 2018). 
34. Geurts SAE, Sonnentag S. Recovery as an explanatory mechanism in the relation 
between acute stress reactions and chronic health impairment. Scand J Work Environ 
Health 2006; 32(6): 482-92. 
35. Lisspers J, Almén N, Sundin Ö. The Effects of a Recovery-Focused Program for 
Stress Management in Women - An Exploratory Study. Health 2014; 06(20): 2825-
36. 
36. Söderstrom M, Jeding K, Ekstedt M, Perski A, Akerstedt T. Insufficient sleep predicts 
clinical burnout. J Occup Health Psychol 2012; 17(2): 175-83. 
37. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of 
the brain. Physiol Rev 2007; 87(3): 873-904. 
38. Ramnero J, Folke F, Kanter JW. A learning theory account of depression. Scand J 
Psychol 2015. 
39. Lejuez CW, Hopko DR, Hopko SD. A brief behavioral activation treatment for 
depression. Treatment manual. Behav Modif 2001; 25(2): 255-86. 
40. Brosschot JF, Gerin W, Thayer JF. The perseverative cognition hypothesis: a review 
of worry, prolonged stress-related physiological activation, and health. J Psychosom 
Res 2006; 60(2): 113-24. 
41. Borkovec TD, Robinson E, Pruzinsky T, DePree JA. Preliminary exploration of 
worry: some characteristics and processes. Behav Res Ther 1983; 21(1): 9-16. 
42. Nolen-Hoeksema S, McBride A, Larson J. Rumination and psychological distress 
among bereaved partners. J Pers Soc Psychol 1997; 72(4): 855-62. 
43. Ebert DD, Berking M, Thiart H, et al. Restoring depleted resources: Efficacy and 
mechanisms of change of an internet-based unguided recovery training for better 
sleep and psychological detachment from work. Health Psychol 2015; 34S: 1240-51. 
44. Vandevala T, Pavey L, Chelidoni O, Chang NF, Creagh-Brown B, Cox A. 
Psychological rumination and recovery from work in intensive care professionals: 
associations with stress, burnout, depression and health. J Intensive Care 2017; 5: 16. 
45. Querstret D, Cropley M. Exploring the relationship between work-related rumination, 
sleep quality, and work-related fatigue. J Occup Health Psychol 2012; 17(3): 341-53. 
46. Chen J, Liu X, Rapee RM, Pillay P. Behavioural activation: a pilot trial of 
transdiagnostic treatment for excessive worry. Behav Res Ther 2013; 51(9): 533-9. 
47. Sonnenschein M, Sorbi MJ, van Doornen LJ, Schaufeli WB, Maas CJ. Evidence that 
impaired sleep recovery may complicate burnout improvement independently of 
depressive mood. J Psychosom Res 2007; 62(4): 487-94. 
48. Ekstedt M, Söderström M, Åkerstedt T, Nilsson J, Søndergaard H-P, Aleksander P. 
Disturbed sleep and fatigue in occupational burnout. Scand J Work Environ Health 
2006; 32(2): 121-31. 
49. Rapee RM, Heimberg RG. A cognitive-behavioral model of anxiety in social phobia. 
Behav Res Ther 1997; 35(8): 741-56. 
  46 
50. Hofmann SG. Cognitive factors that maintain social anxiety disorder: a 
comprehensive model and its treatment implications. Cogn Behav Ther 2007; 36(4): 
193-209. 
51. Heimberg RG, Brozovich FA, Rapee RM. A cognitive behavioral model of social 
anxiety disorder: update and extension. In: Hofmann SG, DiBartolo PM, eds. Social 
Anxiety: Clinical, Developmental, and Social Perspectives, second ed. New York: 
Academic Press; 2010: 395–422. 
52. Clark DM, Wells A. A cognitive model of social phobia. In: Heimberg RG, Leibowitz 
M, Hope DA, Schneider FR, eds. Social phobia: Diagnosis, assessment and treatment. 
New York: Guilford press; 1995: 69-93. 
53. Wong QJJ, Rapee RM. The aetiology and maintenance of social anxiety disorder: A 
synthesis of complimentary theoretical models and formulation of a new integrated 
model. J Affect Disord 2016; 203: 84-100. 
54. Schultz LT, Heimberg RG. Attentional focus in social anxiety disorder: potential for 
interactive processes. Clin Psychol Rev 2008; 28(7): 1206-21. 
55. Penney ES, Abbott MJ. Anticipatory and Post-Event Rumination in Social Anxiety 
Disorder: A Review of the Theoretical and Empirical Literature. Behav Change 2014; 
31(02): 79-101. 
56. Piccirillo ML, Taylor Dryman M, Heimberg RG. Safety Behaviors in Adults With 
Social Anxiety: Review and Future Directions. Behav Ther 2016; 47(5): 675-87. 
57. Clark DM, Ehlers A, McManus F, et al. Cognitive therapy versus fluoxetine in 
generalized social phobia: a randomized placebo-controlled trial. J Consult Clin 
Psychol 2003; 71(6): 1058-67. 
58. Clark DM, Ehlers A, Hackmann A, et al. Cognitive therapy versus exposure and 
applied relaxation in social phobia: A randomized controlled trial. J Consult Clin 
Psychol 2006; 74(3): 568-78. 
59. Hackmann A, Clark DM, McManus F. Recurrent images and early memories in 
social phobia. Behav Res Ther 2000; 38(6): 601-10. 
60. Wild J, Hackmann A, Clark DM. When the present visits the past: updating traumatic 
memories in social phobia. J Behav Ther Exp Psychiatry 2007; 38(4): 386-401. 
61. Oxcadat resources. Resources for cognitive therapy for PTSD, social anxiety disorder 
and panic disorder. https://oxcadatresources.com/questionnaires/ (accessed December 
20, 2018). 
62. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North 
Am 2009; 29(2): 247-64. 
63. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness 
behavior. Brain Behav Immun 2007; 21(2): 153-60. 
64. Schedlowski M, Engler H, Grigoleit JS. Endotoxin-induced experimental systemic 
inflammation in humans: a model to disentangle immune-to-brain communication. 
Brain Behav Immun 2014; 35: 1-8. 
65. Lasselin J, Elsenbruch S, Lekander M, et al. Mood disturbance during experimental 
endotoxemia: Predictors of state anxiety as a psychological component of sickness 
behavior. Brain Behav Immun 2016; 57: 30-7. 
  47 
66. Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. The neuroimmune basis of 
fatigue. Trends Neurosci 2014; 37(1): 39-46. 
67. Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but 
where does the inflammation come from? BMC Med 2013; 11: 200. 
68. Dhabhar FS. Effects of stress on immune function: the good, the bad, and the 
beautiful. Immunol Res 2014; 58(2-3): 193-210. 
69. Marsland AL, Walsh C, Lockwood K, John-Henderson NA. The effects of acute 
psychological stress on circulating and stimulated inflammatory markers: A 
systematic review and meta-analysis. Brain Behav Immun 2017; 64: 208-19. 
70. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a 
meta-analytic study of 30 years of inquiry. Psychol Bull 2004; 130(4): 601-30. 
71. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major 
depression. Biol Psychiatry 2010; 67(5): 446-57. 
72. Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) 
and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major 
depressive disorder: a meta-analysis and meta-regression. J Affect Disord 2012; 
139(3): 230-9. 
73. Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimaki M. Cumulative meta-
analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive 
protein in patients with major depressive disorder. Brain Behav Immun 2015; 49: 206-
15. 
74. Renna ME, O'Toole MS, Spaeth PE, Lekander M, Mennin DS. The association 
between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic 
inflammation: A systematic review and meta-analysis. Depress Anxiety 2018; 35(11): 
1081-94. 
75. Passos IC, Vasconcelos-Moreno MP, Costa LG, et al. Inflammatory markers in post-
traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. 
Lancet Psychiatry 2015; 2(11): 1002-12. 
76. Furtado M, Katzman MA. Neuroinflammatory pathways in anxiety, posttraumatic 
stress, and obsessive compulsive disorders. Psychiatry Res 2015; 229(1-2): 37-48. 
77. Gray SM, Bloch MH. Systematic Review of Proinflammatory Cytokines in 
Obsessive-Compulsive Disorder. Current Psychiatry Reports 2012; 14(3): 220-8. 
78. Vieira MMM, Ferreira TB, Pacheco PAF, et al. Enhanced Th17 phenotype in 
individuals with generalized anxiety disorder. J Neuroimmunol 2010; 229(1-2): 212-
8. 
79. Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and 
Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and 
Experimental Sleep Deprivation. Biol Psychiatry 2015. 
80. Grossi G, Perski A, Evengård B, Blomkvist V, Orth-Gomér K. Physiological 
correlates of burnout among women. J Psychosom Res 2003; 55(4): 309-16. 
81. Jonsdottir IH, Hagg DA, Glise K, Ekman R. Monocyte chemotactic protein-1 (MCP-
1) and growth factors called into question as markers of prolonged psychosocial 
stress. PLoS One 2009; 4(11): e7659. 
  48 
82. Åsberg M, Nygren A, Leopardi R, et al. Novel biochemical markers of psychosocial 
stress in women. PLoS One 2009; 4(1): e3590. 
83. Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review 
and meta-analysis of longitudinal studies. J Affect Disord 2013; 150(3): 736-44. 
84. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the 
directionality of the depression-inflammation relationship. Brain Behav Immun 2009; 
23(7): 936-44. 
85. David D, Cristea I, Hofmann SG. Why Cognitive Behavioral Therapy Is the Current 
Gold Standard of Psychotherapy. Front Psychiatry 2018; 9: 4. 
86. Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a 
meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 2008; 69(4): 
621-32. 
87. Cuijpers P, Sijbrandij M, Koole S, Huibers M, Berking M, Andersson G. 
Psychological treatment of generalized anxiety disorder: a meta-analysis. Clin 
Psychol Rev 2014; 34(2): 130-40. 
88. Mayo-Wilson E, Dias S, Mavranezouli I, et al. Psychological and pharmacological 
interventions for social anxiety disorder in adults: a systematic review and network 
meta-analysis. The Lancet Psychiatry 2014; 1(5): 368-76. 
89. Cusack K, Jonas DE, Forneris CA, et al. Psychological treatments for adults with 
posttraumatic stress disorder: A systematic review and meta-analysis. Clin Psychol 
Rev 2016; 43: 128-41. 
90. Öst LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of 
obsessive-compulsive disorder. A systematic review and meta-analysis of studies 
published 1993-2014. Clin Psychol Rev 2015; 40: 156-69. 
91. Sanchez-Meca J, Rosa-Alcazar AI, Marin-Martinez F, Gomez-Conesa A. 
Psychological treatment of panic disorder with or without agoraphobia: a meta-
analysis. Clin Psychol Rev 2010; 30(1): 37-50. 
92. Wolitzky-Taylor KB, Horowitz JD, Powers MB, Telch MJ. Psychological approaches 
in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev 2008; 28(6): 
1021-37. 
93. Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-
analysis of cognitive-behavioural therapy for adult depression, alone and in 
comparison with other treatments. Can J Psychiatry 2013; 58(7): 376-85. 
94. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. 
Psychological and behavioral treatment of insomnia:update of the recent evidence 
(1998-2004). Sleep 2006; 29(11): 1398-414. 
95. Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive 
Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. 
Ann Intern Med 2015; 163(3): 191-204. 
96. Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E. Guided Internet-based vs. 
face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a 
systematic review and meta-analysis. World Psychiatry 2014; 13(3): 288-95. 
  49 
97. Karyotaki E, Riper H, Twisk J, et al. Efficacy of Self-guided Internet-Based 
Cognitive Behavioral Therapy in the Treatment of Depressive Symptoms: A Meta-
analysis of Individual Participant Data. JAMA Psychiatry 2017; 74(4): 351-9. 
98. Ho FY, Chung KF, Yeung WF, et al. Self-help cognitive-behavioral therapy for 
insomnia: a meta-analysis of randomized controlled trials. Sleep Med Rev 2015; 19: 
17-28. 
99. Bhui KS, Dinos S, Stansfeld SA, White PD. A synthesis of the evidence for managing 
stress at work: a review of the reviews reporting on anxiety, depression, and 
absenteeism. J Environ Public Health 2012; 2012: 515874. 
100. Arends I, Bruinvels DJ, Rebergen DS, et al. Interventions to facilitate return to work 
in adults with adjustment disorders. Cochrane Database Syst Rev 2012; 12: 
CD006389. 
101. Perski O, Grossi G, Perski A, Niemi M. A systematic review and meta-analysis of 
tertiary interventions in clinical burnout. Scand J Psychol 2017; 58(6): 551-61. 
102. Lindsäter E, Axelsson E, Salomonsson S, et al. Internet-Based Cognitive Behavioral 
Therapy for Chronic Stress: A Randomized Controlled Trial. Psychother Psychosom 
2018: 1-10. 
103. Persson Asplund R, Dagoo J, Fjellstrom I, et al. Internet-based stress management for 
distressed managers: results from a randomised controlled trial. Occup Environ Med 
2018; 75(2): 105-13. 
104. van Straten A, Hill J, Richards DA, Cuijpers P. Stepped care treatment delivery for 
depression: a systematic review and meta-analysis. Psychol Med 2015; 45(2): 231-46. 
105. Tolin DF, Diefenbach GJ, Gilliam CM. Stepped care versus standard cognitive-
behavioral therapy for obsessive-compulsive disorder: a preliminary study of efficacy 
and costs. Depress Anxiety 2011; 28(4): 314-23. 
106. Nordgreen T, Haug T, Öst LG, et al. Stepped Care Versus Direct Face-to-Face 
Cognitive Behavior Therapy for Social Anxiety Disorder and Panic Disorder: A 
Randomized Effectiveness Trial. Behav Ther 2016; 47(2): 166-83. 
107. Seekles W, van Straten A, Beekman A, van Marwijk H, Cuijpers P. Stepped care 
treatment for depression and anxiety in primary care. a randomized controlled trial. 
Trials 2011; 12: 171. 
108. Muntingh A, van der Feltz-Cornelis C, van Marwijk H, et al. Effectiveness of 
collaborative stepped care for anxiety disorders in primary care: a pragmatic cluster 
randomised controlled trial. Psychother Psychosom 2014; 83(1): 37-44. 
109. Oosterbaan DB, Verbraak MJ, Terluin B, et al. Collaborative stepped care v. care as 
usual for common mental disorders: 8-month, cluster randomised controlled trial. Br J 
Psychiatry 2013; 203(2): 132-9. 
110. Salomonsson S, Hedman-Lagerlöf E, Öst LG. Sickness absence: a systematic review 
and meta-analysis of psychological treatments for individuals on sick leave due to 
common mental disorders. Psychol Med 2018; 48(12): 1954-65. 
111. Loerinc AG, Meuret AE, Twohig MP, Rosenfield D, Bluett EJ, Craske MG. 
Response rates for CBT for anxiety disorders: Need for standardized criteria. Clin 
Psychol Rev 2015; 42: 72-82. 
  50 
112. Taylor S, Abramowitz JS, McKay D. Non-adherence and non-response in the 
treatment of anxiety disorders. J Anxiety Disord 2012; 26(5): 583-9. 
113. Santoft F, Axelsson E, Öst LG, Hedman-Lagerlöf M, Fust J, Hedman-Lagerlöf E. 
Cognitive behaviour therapy for depression in primary care: systematic review and 
meta-analysis. Psychol Med 2019: 1-9. 
114. Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu 
Rev Clin Psychol 2007; 3: 1-27. 
115. Zalta AK. Psychological mechanisms of effective cognitive-behavioral treatments for 
PTSD. Curr Psychiatry Rep 2015; 17(4): 560. 
116. Doss BD. Changing the Way We Study Change in Psychotherapy. Clinical 
Psychology: Science and Practice 2004; 11(4): 368-86. 
117. Kazdin AE. Evidence-based psychotherapies I: qualifiers and limitations in what we 
know. South African Journal of Psychology 2014; 44(4): 381-403. 
118. Baron RM, Kenny DA. The moderator-mediator variable distinction in social 
psychological research: conceptual, strategic, and statistical considerations. J Pers 
Soc Psychol 1986; 51(6): 1173-82. 
119. MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol 2007; 
58: 593-614. 
120. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of 
treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002; 59(10): 
877-83. 
121. Arch JJ, Craske MG. Acceptance and commitment therapy and cognitive behavioral 
therapy for anxiety disorders: Different treatments, similar mechanisms? Clinical 
Psychology: Science and Practice 2008; 15(4): 263-79. 
122. Manos RC, Kanter JW, Busch AM. A critical review of assessment strategies to 
measure the behavioral activation model of depression. Clin Psychol Rev 2010; 30(5): 
547-61. 
123. Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of 
the brief behavioral activation treatment for depression: revised treatment manual. 
Behav Modif 2011; 35(2): 111-61. 
124. Dimaggio G, Shahar G. Behavioral activation as a common mechanism of change 
across different orientations and disorders. Psychotherapy (Chic) 2017; 54(3): 221-4. 
125. Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure 
therapy: an inhibitory learning approach. Behav Res Ther 2014; 58: 10-23. 
126. Craske MG, Kircanski K, Zelikowsky M, Mystkowski J, Chowdhury N, Baker A. 
Optimizing inhibitory learning during exposure therapy. Behav Res Ther 2008; 46(1): 
5-27. 
127. Clark DA. Cognitive Restructuring.  The Wiley Handbook of Cognitive Behavioral 
Therapy; 2013: 1-22. 
128. Jacobson NS, Dobson KS, Truax PA, et al. A component analysis of cognitive-
behavioral treatment for depression. J Consult Clin Psychol 1996; 64(2): 295-304. 
  51 
129. Garratt G, Ingram RE, Rand KL, Sawalani G. Cognitive processes in cognitive 
therapy: Evaluation of the mechanisms of change in the treatment of depression. 
Clinical Psychology-Science and Practice 2007; 14(3): 224-39. 
130. Ebert DD, Lehr D, Heber E, Riper H, Cuijpers P, Berking M. Internet- and mobile-
based stress management for employees with adherence-focused guidance: efficacy 
and mechanism of change. Scand J Work Environ Health 2016; 42(5): 382-94. 
131. Lloyd J, Bond FW, Flaxman PE. The value of psychological flexibility: Examining 
psychological mechanisms underpinning a cognitive behavioural therapy intervention 
for burnout. Work Stress 2013; 27(2): 181-99. 
132. Deci EL, Ryan RM. The "What" and "Why" of Goal Pursuits: Human Needs and the 
Self-Determination of Behavior. Psychol Inq 2000; 11(4): 227-68. 
133. Fluckiger C, Del Re AC, Wampold BE, Horvath AO. The alliance in adult 
psychotherapy: A meta-analytic synthesis. Psychotherapy (Chic) 2018; 55(4): 316-40. 
134. Horvath AO. The alliance in context: Accomplishments, challenges, and future 
directions. Psychotherapy (Chic) 2006; 43(3): 258-63. 
135. Furmark T, Holmström A, Sparthan E, Carlbring P, Andersson G. Social fobi : 
effektiv hjälp med kognitiv beteendeterapi. Stockholm: Liber; 2013. 
136. Foa EB, Franklin ME, Perry KJ, Herbert JD. Cognitive biases in generalized social 
phobia. J Abnorm Psychol 1996; 105(3): 433-9. 
137. McManus F, Clark DM, Hackmann A. Specificity of cognitive biases in social phobia 
and their role in recovery. Behav Cogn Psychother 2000; 28(3): 201-9. 
138. Hofmann SG. Cognitive mediation of treatment change in social phobia. J Consult 
Clin Psychol 2004; 72(3): 393-9. 
139. Rapee RM, Gaston JE, Abbott MJ. Testing the efficacy of theoretically derived 
improvements in the treatment of social phobia. J Consult Clin Psychol 2009; 77(2): 
317-27. 
140. Calamaras MR, Tully EC, Tone EB, Price M, Anderson PL. Evaluating changes in 
judgmental biases as mechanisms of cognitive-behavioral therapy for social anxiety 
disorder. Behav Res Ther 2015; 71: 139-49. 
141. O'Toole MS, Mennin DS, Hougaard E, Zachariae R, Rosenberg NK. Cognitive and 
Emotion Regulation Change Processes in Cognitive Behavioural Therapy for Social 
Anxiety Disorder. Clin Psychol Psychother 2014. 
142. Abbott MJ, Rapee RM. Post-event rumination and negative self-appraisal in social 
phobia before and after treatment. J Abnorm Psychol 2004; 113(1): 136-44. 
143. Boden MT, John OP, Goldin PR, Werner K, Heimberg RG, Gross JJ. The role of 
maladaptive beliefs in cognitive-behavioral therapy: Evidence from social anxiety 
disorder. Behav Res Ther 2012; 50(5): 287-91. 
144. Hofmann SG. Self-focused attention before and after treatment of social phobia. 
Behav Res Ther 2000; 38(7): 717-25. 
145. Hoffart A, Borge FM, Clark DM. Within-person process-outcome relationships in 
residential cognitive and interpersonal psychotherapy for social anxiety disorder: A 
reanalysis using disaggregated data. Journal of Experimental Psychopathology 2016; 
7(4): 671-83. 
  52 
146. Hedman E, Mörtberg E, Hesser H, et al. Mediators in psychological treatment of 
social anxiety disorder: individual cognitive therapy compared to cognitive behavioral 
group therapy. Behav Res Ther 2013; 51(10): 696-705. 
147. Mörtberg E, Hoffart A, Boecking B, Clark DM. Shifting the focus of one's attention 
mediates improvement in cognitive therapy for social anxiety disorder. Behav Cogn 
Psychother 2015; 43(1): 63-73. 
148. Aderka IM, McLean CP, Huppert JD, Davidson JR, Foa EB. Fear, avoidance and 
physiological symptoms during cognitive-behavioral therapy for social anxiety 
disorder. Behav Res Ther 2013; 51(7): 352-8. 
149. Smits JA, Rosenfield D, McDonald R, Telch MJ. Cognitive mechanisms of social 
anxiety reduction: an examination of specificity and temporality. J Consult Clin 
Psychol 2006; 74(6): 1203-12. 
150. Niles AN, Burklund LJ, Arch JJ, Lieberman MD, Saxbe D, Craske MG. Cognitive 
mediators of treatment for social anxiety disorder: comparing acceptance and 
commitment therapy and cognitive-behavioral therapy. Behav Ther 2014; 45(5): 664-
77. 
151. Keri S, Szabo C, Kelemen O. Expression of Toll-Like Receptors in peripheral blood 
mononuclear cells and response to cognitive-behavioral therapy in major depressive 
disorder. Brain Behav Immun 2014; 40: 235-43. 
152. Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the 
tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role 
of baseline inflammatory biomarkers. JAMA Psychiatry 2013; 70(1): 31-41. 
153. Euteneuer F, Dannehl K, Del Rey A, Engler H, Schedlowski M, Rief W. 
Immunological effects of behavioral activation with exercise in major depression: an 
exploratory randomized controlled trial. Transl Psychiatry 2017; 7(5): e1132. 
154. Gazal M, Souza LD, Fucolo BA, et al. The impact of cognitive behavioral therapy on 
IL-6 levels in unmedicated women experiencing the first episode of depression: a 
pilot study. Psychiatry Res 2013; 209(3): 742-5. 
155. Dahl J, Ormstad H, Aass HC, et al. The plasma levels of various cytokines are 
increased during ongoing depression and are reduced to normal levels after recovery. 
Psychoneuroendocrinology 2014; 45: 77-86. 
156. Moreira FP, Cardoso Tde A, Mondin TC, et al. The effect of proinflammatory 
cytokines in Cognitive Behavioral Therapy. J Neuroimmunol 2015; 285: 143-6. 
157. Irwin MR, Olmstead R, Carrillo C, et al. Cognitive Behavioral Therapy vs. Tai Chi 
for Late Life Insomnia and Inflammatory Risk: A Randomized Controlled 
Comparative Efficacy Trial. Sleep 2014; 37(9): 1543-U361. 
158. Memon AA, Sundquist K, Ahmad A, Wang X, Hedelius A, Sundquist J. Role of IL-8, 
CRP and epidermal growth factor in depression and anxiety patients treated with 
mindfulness-based therapy or cognitive behavioral therapy in primary health care. 
Psychiatry Res 2017; 254: 311-6. 
159. Dahl J, Ormstad H, Aass HC, Sandvik L, Malt UF, Andreassen OA. Recovery from 
major depressive disorder episode after non-pharmacological treatment is associated 
with normalized cytokine levels. Acta Psychiatr Scand 2016; 134(1): 40-7. 
  53 
160. Lopresti AL. Cognitive behaviour therapy and inflammation: A systematic review of 
its relationship and the potential implications for the treatment of depression. Aust N Z 
J Psychiatry 2017; 51(6): 565-82. 
161. Di Nardo P, Moras K, Barlow DH, Rapee RM, Brown TA. Reliability of DSM-III-R 
anxiety disorder categories. Using the Anxiety Disorders Interview Schedule-Revised 
(ADIS-R). Arch Gen Psychiatry 1993; 50(4): 251-6. 
162. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A 
comparison of cognitive therapy, applied relaxation and imipramine in the treatment 
of panic disorder. Br J Psychiatry 1994; 164(6): 759-69. 
163. Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M. Cognitive therapy for 
post-traumatic stress disorder: development and evaluation. Behav Res Ther 2005; 
43(4): 413-31. 
164. Öst LG. Applied relaxation: description of a coping technique and review of 
controlled studies. Behav Res Ther 1987; 25(5): 397-409. 
165. Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebo-controlled trial of 
exposure and ritual prevention, clomipramine, and their combination in the treatment 
of obsessive-compulsive disorder. Am J Psychiatry 2005; 162(1): 151-61. 
166. Morin CM. Insomnia : psychological assessment and management. New York: 
Guilford Press; 1993. 
167. van der Klink JJ, Blonk RW, Schene AH, van Dijk FJ. Reducing long term sickness 
absence by an activating intervention in adjustment disorders: a cluster randomised 
controlled design. Occup Environ Med 2003; 60(6): 429-37. 
168. Hoefsmit N, Houkes I, Nijhuis FJ. Intervention characteristics that facilitate return to 
work after sickness absence: a systematic literature review. Journal of Occupational 
Rehabilitation 2012; 22(4): 462-77. 
169. Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for 
posttraumatic stress disorder (PTSD): Randomized controlled trial. Depress Anxiety 
2017; 34(6): 555-65. 
170. Carlbring P, Hanell, Å. Ingen panik : fri från panik- och ångestattacker i 10 steg med 
kognitiv beteendeterapi. Stockholm: Natur & Kultur; 2011. 
171. Öst LG. Applied relaxation: manual of a behavioral coping-strategy. Stockholm: 
Lars-Göran Öst; 2006. 
172. Asplund M, Rosengren, E-L. Fri från tvång. Steg för steg med kognitiv 
beteendeterapi. Stockholm: Natur och Kultur; 2012. 
173. Andersson B, Holländare,  Lenndin & Vernmark. Ut ur depression och nedstämdhet 
med kognitiv beteendeterapi, ett effektivt självhjälpsprogram: Viva; 2007. 
174. Jernelöv S. Sov gott!: Råd och tekniker från KBT. Stockholm: Wahlström & 
Widstrand; 2008. 
175. Melamed S, Kushnir T, Shirom A. Burnout and risk factors for cardiovascular 
diseases. Behav Med 1992; 18(2): 53-60. 
176. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an 
outcome measure for insomnia research. Sleep Med 2001; 2(4): 297-307. 
  54 
177. Kanter JW, Mulick PS, Busch AM, Berlin KS, Martell CR. The Behavioral 
Activation for Depression Scale (BADS): Psychometric Properties and Factor 
Structure. Journal of Psychopathology and Behavioral Assessment 2006; 29(3): 191-
202. 
178. Williams GC, McGregor HA, Sharp D, et al. Testing a self-determination theory 
intervention for motivating tobacco cessation: Supporting autonomy and competence 
in a clinical trial. Health Psychol 2006; 25(1): 91-101. 
179. Williams GC, Wiener MW, Markakis KM, Reeve J, Deci EL. Medical students' 
motivation for internal medicine. J Gen Intern Med 1994; 9(6): 327-33. 
180. Tracey TJ, Kokotovic AM. Factor structure of the Working Alliance Inventory. 
Psychological Assessment: A Journal of Consulting and Clinical Psychology 1989; 
1(3): 207-10. 
181. Baker SL, Heinrichs N, Kim HJ, Hofmann SG. The liebowitz social anxiety scale as a 
self-report instrument: a preliminary psychometric analysis. Behav Res Ther 2002; 
40(6): 701-15. 
182. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987; 22: 141-73. 
183. Svanborg P, Asberg M. A new self-rating scale for depression and anxiety states 
based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 
1994; 89(1): 21-8. 
184. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health 
Soc Behav 1983; 24(4): 385-96. 
185. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr 
Scand 1983; 67(6): 361-70. 
186. World Medical Association. World Medical Association Declaration of Helsinki: 
ethical principles for medical research involving human subjects. JAMA 2013; 
310(20): 2191-4. 
187. Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The Efficacy of Cognitive 
Behavioral Therapy: A Review of Meta-analyses. Cognit Ther Res 2012; 36(5): 427-
40. 
188. Twomey C, O'Reilly G, Byrne M. Effectiveness of cognitive behavioural therapy for 
anxiety and depression in primary care: a meta-analysis. Fam Pract 2014. 
189. Nieuwenhuijsen K, Faber B, Verbeek JH, et al. Interventions to improve return to 
work in depressed people. Cochrane Database Syst Rev 2014; 3(12). 
190. Nigatu YT, Liu Y, Uppal M, et al. Interventions for enhancing return to work in 
individuals with a common mental illness: systematic review and meta-analysis of 
randomized controlled trials. Psychol Med 2016; 46(16): 3263-74. 
191. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh 
Sleep Quality Index: a new instrument for psychiatric practice and research. 
Psychiatry Res 1989; 28(2): 193-213. 
192. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 
1977; 84(2): 191-215. 
  55 
193. Hahn VC, Binnewies C, Sonnentag S, Mojza EJ. Learning how to recover from job 
stress: effects of a recovery training program on recovery, recovery-related self-
efficacy, and well-being. J Occup Health Psychol 2011; 16(2): 202-16. 
194. Sonnentag S, Venz L, Casper A. Advances in recovery research: What have we 
learned? What should be done next? J Occup Health Psychol 2017; 22(3): 365-80. 
195. Sonnentag S, Fritz C. The Recovery Experience Questionnaire: development and 
validation of a measure for assessing recuperation and unwinding from work. J Occup 
Health Psychol 2007; 12(3): 204-21. 
196. Hoffart A, Borge FM, Sexton H, Clark DM, Wampold BE. Psychotherapy for social 
phobia: how do alliance and cognitive process interact to produce outcome? 
Psychotherapy research : journal of the Society for Psychotherapy Research 2012; 
22(1): 82-94. 
197. Öst LG. Cognitive behavior therapy for anxiety disorders: 40 years of progress. 
Nordic journal of psychiatry 2008; 62 Suppl 47: 5-10. 
198. Dallery J, Cassidy RN, Raiff BR. Single-case experimental designs to evaluate novel 
technology-based health interventions. J Med Internet Res 2013; 15(2): e22. 
199. Raison CL, Miller AH. Is depression an inflammatory disorder? Curr Psychiatry Rep 
2011; 13(6): 467-75. 
200. Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA. ELISA and 
multiplex technologies for cytokine measurement in inflammation and aging research. 
J Gerontol A Biol Sci Med Sci 2008; 63(8): 879-84. 
201. Nilsonne G, Lekander M, Akerstedt T, Axelsson J, Ingre M. Diurnal Variation of 
Circulating Interleukin-6 in Humans: A Meta-Analysis. PLoS One 2016; 11(11): 
e0165799. 
202. Olsson EMG, Norlund F, Pingel R, et al. The effect of group-based cognitive 
behavioral therapy on inflammatory biomarkers in patients with coronary heart 
disease-results from the SUPRIM-trial. Ups J Med Sci 2018; 123(3): 167-73. 
203. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary 
imperative to modern treatment target. Nat Rev Immunol 2016; 16(1): 22-34. 
204. Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ. 
Inflammation and clinical response to treatment in depression: A meta-analysis. Eur 
Neuropsychopharmacol 2015; 25(10): 1532-43. 
205. Lasselin J, Kemani MK, Kanstrup M, et al. Low-grade inflammation may moderate 
the effect of behavioral treatment for chronic pain in adults. J Behav Med 2016; 39(5): 
916-24. 
206. Harley J, Luty S, Carter J, Mulder R, Joyce P. Elevated C-reactive protein in 
depression: a predictor of good long-term outcome with antidepressants and poor 
outcome with psychotherapy. J Psychopharmacol 2010; 24(4): 625-6. 
207. Zahn D, Herpertz S, Albus C, et al. hs-CRP Predicts Improvement in Depression in 
Patients With Type 1 Diabetes and Major Depression Undergoing Depression 
Treatment: Results From the Diabetes and Depression (DAD) Study. Diabetes Care 
2016; 39(10): e171-3. 
208. Duivis HE, de Jonge P, Penninx BW, Na BY, Cohen BE, Whooley MA. Depressive 
symptoms, health behaviors, and subsequent inflammation in patients with coronary 
  56 
heart disease: prospective findings from the heart and soul study. Am J Psychiatry 
2011; 168(9): 913-20. 
209. O'Toole MS, Bovbjerg DH, Renna ME, Lekander M, Mennin DS, Zachariae R. 
Effects of psychological interventions on systemic levels of inflammatory biomarkers 
in humans: A systematic review and meta-analysis. Brain Behav Immun 2018. 
210. Lynch KG, Cary M, Gallop R, Ten Have TR. Causal Mediation Analyses for 
Randomized Trials. Health Serv Outcomes Res Methodol 2008; 8(2): 57-76. 
211. Hamaker EL. Why researchers should think "within-person": A paradigmatic 
rationale.  Handbook of research methods for studying daily life. New York, NY, US: 
Guilford Press; 2012: 43-61. 
212. Kuckertz JM, Gildebrant E, Liliequist B, et al. Moderation and mediation of the effect 
of attention training in social anxiety disorder. Behav Res Ther 2014; 53: 30-40. 
 
 
